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1 3 SUMMARY 
The  tests  used  in  the  diagnosis  of  a  thalassaemia 
trait  include  measurement  of  red  cell  indices, 
measurement  of  HbA 2 ,  measurement  of  serum  ferritin, 
demonstration  of  HbH  inclusions  and  globin  chain 
synthesis  ratios.  The efficacy  of  these  tests  to 
substantiate  this  diagnosis  may  be  impaired  unless 
certain  variables  are  carefully  controlled  and,  In  the 
mild  form  of  the  disorder,  diagnosis  may  not  be  possible 
without  resort  to  gene  mapping  techniques.  In  addition, 
the  heterogeneity  of  the  disorder  becomes  apparent  when 
studying  patients  from  different  ethnic  groups. 
Complicating  disorders  e.g.  co-existent  iron  deficiency 
compound  the  diagnostic  problem. 
The  main  aims  of  this  study  are:-
1.  Assessment  of  red  cell  volume  distribution  as  a  means 
of  different~ating a  thalassaemia  trait  from  iron 
deficiency. 
2.  Assessment  of  the  effect  of  different  variables  on 
the  performance  of  HbH  inclusion  testing: 
(a)  Variation  in  incubation  temperature. 
(b)  Variation  In  incubation  time. 
(c)  Use  of  potassium  iodide  as  a  stimulant. 
(d)  Use  of  centrifuged  blood  methods  as  an  alternative 
to  the  traditional  whole  blood  method. 
3.  Assessment  of  the  reliability  of  HbH  inclusion  testing 
in  the  diagnosis  of  all  forms  of  a  thalassaemia  trait 
in  different  ethnic  groups. 
4.  Assessment  of  globin  chain  synthesis  ratios  to  diagnose 
the  existence  of  a  thalassaemia  trait. 5.  Study  of  the  heterogeneity  of  a  thalassaemia  trait 
in  different  races. 
The  following  conclusions  were  reached:-
1 .  Red  cell  volume  distribution  analysis  using  the  red 
distribution  width  (RDW)  parameter  produced  by  the 
Coulter  Counter  Model  S  Plus  IV  is  a  useful 
measurement  for  distinguishing  uncomplicated  a 
thalassaemia  trait  from  iron  deficiency. 
2.  Standardisation  of  a  number  of  variables  IS  of 
importance  in  achieving  the  best  results  in  HbH 
inclusion  testing: 
(a)  HbH  inclusions  develop  more  rapidly  when 
incubation  is  conducted  at  37°C  rather  than  25°C . 
. 
(b)  In  general,  the  rate  of  development  of  HbH 
inclusions  increases  In  direct  proportion  to  the 
time  of  incubation.  However,  incubation  of 
control  blood  for  2  hours  at  37°C  results  in  the 
emergence  of  false  positive  results. 
(c)  The  use  of  potassium  iodide  as  a  stimulant  does 
not  show  any  advantage. 
(d)  The  use  of  centrifugation  techniques  increases  the 
number  of  inclusions  seen  particularly  in  the 
severe  form  of  the  disorder,  but  did  not  increase 
the  diagnostic  yield  in  the  mild  form. 
3.  The  HbH  inclusion  test  proved  unreliable  in  the 
diagnosis  of  mild  forms  of  a  thalassaemia  trait. 
4.  Globin  chain  synthesis  studies  showed  statistically 
1 5 significant  differences  between  controls  and  mild 
forms  of  the  disorder  and  between  mild  and  severe 
forms  of  the  disorder.  However,  some  overlap  of  results 
occurred  between  control  subjects  and  patients  with 
mild  forms  therefore  this  test  must  be  considered 
; 
unsuitable  in  a  proportion  of  patients with  mild 
a  thalassaemia  trait. 
5.  Examples  of  a  thalassaemia  trait  were  found  In 
patients  of  Indian,  Chinese  and  Negro  origin.  In 
spite  of  reports  to  the  contrary,  the  severe  form 
of  the  trait  was  identified  in  a  significant  proportion 
of  Indian  patients.  A  comparison  of  the  severe  form 
In  Indian  and  Chinese  subjects  revealed  di~ferences 
In  the  number  of  HbH  inclusions  demonstrable  and  in 
the  degree  of  suppression  of  globin  chain  synthesis. 
1 6 INTRODUCTION 
1 7 1 .  GENERAL  INTRODUCTION 
The  thalassaemias  are  a  group  of  inherited  disorders 
of  haemoglobin  synthesis  which  result  from  a  deficiency  of 
either  the  a  or  6.chains  of  haemoglobin.  The  a 
thalassaemia  syndromes  are  a  common  worldwide  group  of 
disorders  which  result  from  inherited  defects  in  the  rate 
of  synthesis  of  the  a  globin  chain.  Since  a  chains  are 
present  in  both  foetal  (Hb~a2Y2)  and  adult  haemoglobins 
( H  b A,a 2 6 2 ),  a  d e f i c i e n c y  0 f  a  c h a i n  pro  d u c t ion  will  a f f e c t 
haemoglobin  synthesis  in  foetal  as  well  as  in  adult  life. 
A  reduced  rate  of  a  chain  synthesis  in  foetal  life  results 
in  an  excess  of  y  chains,  which  form  Y4  tetramers  or 
haemoglobin  Bart's.  In  adult  life  a  deficiency  of  a  chains 
results  in  an  excess  of  6  chains  which  form  6
4 
tetramers 
or  haemoglobin  H. 
The  extent  of  the  a  chain  deficit  IS  very  variable 
and  is  usually  associated  with  four  major  clinical 
manifestations  in  most  ethnic  groups:-
(a)  a  thalassaemia  2,  the  milder  form  of  the  hete~ozygous 
state  which  is  either  silent  or  causes  only  mild  red 
cell  changes. 
(b)  a  thalassaemia  1  which  IS  a  more  severe  variety  of 
the  heterozygous  state  resulting  In  the  appearance 
of  microcytic  red  cells,  but  little or  no  anaemIa. 
(c)  Haemoglobin  H  disease,  usually  a  combination  of 
a  thalassaemia  2  and  a  thalassaemia  1,  resulting 
in  mild  to  moderate  anaemia  with  marked  morphological 
changes  in  the  red  cells. 
18 (d)  Haemoglobin  Bart's  hydrops  foetalis  syndrome 
(HBHFS)  an  invariably  fatal  condition  which 
represents  the  homozygous  state  of  a  thalassaemia  1. 
The  first  form  of  a  thalassaemia  to  be  recognised 
was  HbH  disease,  which  was  described  independently  in 
the  United  States  and  in  Greece  in  1955  (Rigas  et  aI, 
1955:  Gouttas  et  aI,  1955).  Jones  et  al  (1959) 
suggested  that  HbH  results  from  a  deficiency  in  a-
globin  chains  since  it  was  shown  to  consist  solely  of 
B chains. 
In  1958  haemoglobin  Bart's  was  described  by  Ager 
and  Lehmann. - Fessas  (1960)  assumed  that  this  haemoglobin 
also  resulted  from  a  deficiency  of  a  chains  and  was  the 
foetal  counterpart  of  HbH. 
In  1960  Lie-Injo  and  Jo  described  a  stillborn 
Indonesian  infant  whose  haemoglobin  consisted  almost 
entirely  of  Hb  Bart's.  This  was  the  first  report  of  the 
entity  now  recognised  as  haemoglobin  Bart's  hydrops 
foetalis  syndrome  (HBHFS). 
Su~sequently  an  extensive  series  of  genetic  studies 
on  the  various  forms  of  a  thalassaemia  in  Thailand 
(Wasi  et  aI,  1964;  Pootrakul  et  aI,  1967;  Na-Nakorn  et 
aI,  1969)  suggested  that  the  disease  resulted  from  the 
interaction  of  two  main  a  thalassaemia  determinants, 
a  thalassaemia  2  and  a  thalassaemia  1. 
2.  GENETICS  OF  a  THALASSAEMIA 
Although  a  thalassaemia  clearly  has  a  wide 
geographical  distribution,  initially  there  appeared  to 
ben  0  straight  forward  genetic  patterns  which  explained 
1 9 the  inheritance  of  a  thalassaemia  In  all  populations 
(Higgs  and  Weatherall,  1983). 
There  were  two  hypotheses  proposed  in  the  1970's 
to  explain  the  genetic  basis  of  a  thalassaemia.  One 
hypothesis  based  on  family  studies  in  Thailand  where 
a  thalassaemia  is  common,  proposed  the  existence  of  a 
single  a  chain  locus  and  two  thalassaemia  alleles'  the  a  , 
thalassaemia  1  allele  caused  complete  inhibition  of 
a-chain  synthesis.  The  observed  phenotype  of  HbH 
disease  was  the  result  of  interaction  of  these  two  genes. 
This  hypothesis  IS  no  longer  tenable  (Na-Nakorn  and  Wasi, 
1970).  The  second  hypothesis  remains  partially  tenable 
and  was  based  on  evidence  that  the  a  globin  structural 
gene  IS  duplicated  (Lehmann  and  Carrell,  1968; 
Lehmann,  1970).  A  normal  individual  would,  on  this 
evidence,  possess  four  a  globin  genes  I.e.  (aa/aa). 
a  thalass~emia  would  then  result  from  gene  deletion, 
the  severity  depending  on  the  number  of  a  chain  genes 
deleted  up  to  a  maximum  of  four  (Kan  et  ~l,  1975).  This 
hypothesis  explains  the  inheritance  of  a  thalassaemia 
In  most  human  populations. 
This  gene  deletion,  thought  to  be  the  basic 
abnormality  in  a  thalassaemia,  results  in  a  deficiency 
or  absence  of  functional  a  globin  messenger  ribonucleic 
acid  (mRNA).  The  nature  of  the  underlying  defect 
responsible  for  the  decrease  in  a  mRNA  production  has 
been  studied.  Two  groups  (Ottolenghi  et  aI,  1974: 
Taylor  et  aI,  1974)  were  able  to  show  by  hybridisation 
of  deoxyribonucleic  acid  (DNA)  and  radioactive 
20 synthesised  DNA  copy  (DNA c)'  DNA/DNA c '  that  the  a  chain 
genes  are  substantially,  if  not  completely,  deleteg  in 
homozygous  a  thalassaemia  1  (Hb  8art's  hydrops  foetalis). 
These  studies  were  the  first  demonstration  of  gene 
deletion  as  a  cause  of  a  thalassaemia.  The  same 
technique  has  been  used  (Kan  et  aI,  1975)  to  demonstrate 
deletion  of  three-quarters  of  the  normal  complement  of 
a  globin  genes  (HbH  disease).  These  results  indicated 
that  a  thalassaemia  2  patients  have  three  functional 
a  globin  genes  (aal-a);  a  thalassaemia  1  trait  subjects 
have  two  (--Iaa);  individuals  with  haemoglobin  H 
dis  e a s e  h a v e  one (-- I -a),  and  in fan t s  wit h  h a e m  0 g lob i n 
8art's  hydrops  foetalis  syndrome  have  none. 
More  extensive  genetic  studies  followed  which 
described  the  structure  of  a-globin  genes.  In  1977, 
Diesseroth  et  al  reported  that  a-globin  genes  were 
located  on  chromosome  16.  Using  a  Southern  blotting 
technique  (cleavage  of  DNA  molecules  into  fragments  by 
enzymes)  it  was  shown  that  the  a-globin  genes  on  each 
chromosome  are  duplicated  and  separated  by  approximately 
3.0  kb  (kilobase  pairs)  of  non-coding  DNA  (Orkin,  1978). 
Lauer  et  al  (1980)  using  a  radioactive  labelled  a-globin 
DNA  probe,  studied  the  fine  structure  of  a  genes. 
c 
isolated  a  cluster  of  five  a-like  globin  genes.  In 
They 
addition  to  the  a  genes  (a1  and  a2)  they  also  identified 
a  pseudo  a  gene  (Wa1,  a  non-functional  a  globin-like 
DNA  sequence)  and  two  embryonic  a-like  globin  genes(s1 
and  s2)  within  a  26  Kb  stretch  of  DNA.  These  genes 
21 are  arranged  along  the  chromosome  in  the  order  in  which 
they  are  expressed  during  development  5' -~2-~'-~1-a2-
I 
a1-3  (Figure  1).  Each  gene  is  located  in  a  region  of 
homology  approximately  4Kb  long,  interrupted  by  two  small 
non-homologous  regions  (Orkin,  1978  Lauer  et  aI,  1980: 
Liebhaber  et  aI,  1981)  (Figure  2 ) . 
It  IS  thought  t hat  the  homologous  regIons  have 
resulted  from  an  ancient  duplication  event  and  that  the 
non-homologous  segments  may  have  subsequently  arisen  by 
insertion  of  DNA  into  the  non-coding  region  around  one  of 
the  two  genes  (Fritsch  et  aI,  1980). 
The  structure  of  each  a  gene  conforms  to  the  general 
pattern  observed  for  all  globin  genes.  It  consists  of 
three  coding  regIons  (exons)  and  two  intervening  sequences 
(introns)  as  illustrated  in  Figure3.  Comparison  of  the 
a1  and  a2  coding  sequences  has  revealed  no  differences  in 
exons  1,  2  or  3  (Liebhaber  et  aI,  1981).  The  first  intron 
in  each  gene  is  identical  but  the  second  intron  of  a1  is 
nine  bases  longer  and  differs  by  three  bases  from  that  In 
the  a2  gene  (Liebhaber  et  aI,  1980).  In  eaoh  gene  the 
start  codon  is  Thymine,  Adenine,  Guanine  (TAG)  and  the 
terminator  is  Thymine,  Adenine,  Adenine  (TAA).  The  exon/ 
intron  junctions  all  conform  to  the  Chambon  rule  (5  -GT/ 
AG-3  )which  appears  to  be  a  requisite  for  normal  splicing 
of  nuclear  mRNA  (Breathnach  et  aI,  1981).  The  ~1  and 
~2  genes  are  also  highly  homologous.  The  introns  are  much 
larger,  than  those  found  in  the  a-globin  genes  (Higgs  and 
Weatherall,  1983).  There  are  three  base  changes  in  the 
coding  sequence  of  the  first  exon  of  ~1,  one  of  which 
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FIGURE  2:  Details  of  homologous  regIons  x,  y  and  z 
surrounding  the  a1- and  a2-genes. 
Reproduced  from  Alpha  Thalassaemia  by  Higgs  and 
Weatherall  in  Current  Topics  In  Haematology  (1983), 
with  kind  permission  of  Alan  R.  Liss,  Inc.,  publishers. Kb  0  10  20  30 
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The  a  globin  gene  cluster.  The  a2  gene  has 
been  enlarged  to  show  the  non-coding  regions  (hatched), 
the  exons(dark  shading),  and  introns  (unshaded). 
Reproduced  from  Molecular  Pathology  of  Thalassaemia  by 
Weatherall  and  Wainscoat  in  Recent  Advances  In 
Haematology  (1985),  with  kind  permission  of  Churchill 
Livingstone,  publishers. gives  rlse  to  a  premature  stop  codon.  Thus  it  appears 
that  ~1  is  an  inactive  pseudo-gene  (Proudfoot,  1982). 
Recent  studies  showed  that  variation  in  the  clinical 
syndromes  and  patterns  of  inheritance  of  a  thalassaemia 
are  due  to  diversity  in  the  underlying  molecular  defects 
rather  than  variation  in  the  number  of  a-genes  present 
in  non-thalassaemic  individuals  (Higgs  and  Weatherall, 
1983).  Alpha  thalassaemia  2  and  a  thalassaemia  1  could 
therefore  be  further  classified  into  those  which  are  due 
to  deletion  from  the  a-gene  complex,  and  "-non-deletion"  or 
mutations  in  which  the  complex  appears  to  be  intact. 
Last  year,  Weatherall  and  Wainscoat  (1985)  described 
the  simplest  way  in  which  this  disorder  might  arise 
(Figure  4).  In  this  model  they  showed  that  a-thalassaemia 
2  results  from  the  deletion  of  only  one  of  the  pair  of 
a-globin  genes  whereas  a  thalassaemia  1  results  from  the 
deletion  (loss)  of  both  the  linked  a-globin  genes  (a1  and 
a2 ) .  It  turns  out  that  a  thalassaemia  1  trait  is  due  to 
deletions  which  remove  both  a-globin  genes.  However, 
a  thalassaemia  2  trait  can  be  due  to  either  gene  deletion 
or  alternatively  to  mutations  which  inactivate  them 
partly  or  completely. 
2.1  Deletion  Types  of  a  Thalassaemia 
2 . 1 . 1  a  thalassaemia  2 
In  the  deletion  forms,  different  size  deletions 
(3.7  and  4.2  kb)  remove  one  a  globin  gene  and  leave 
one  functional  a  gene  per  haploid  genome  (-a) 
(Figure  5).  These  lesions  are  thought  to  have  arisen 
by  unequal  crossover  between  homologous  pairs  on 
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FIGURE  4:  Models  for  the  transmission  of  a 
thalassaemia  1  and  a  thalassaemia  2  and  the  production 
of  Hb  Bart's  Hydrops  and  HbH  disease.  Normal  a  loci 
are  shown  by  the  open  boxes  and  deleted  or  non-deleted 
a  thalassaemia  genes  by  the  shaded  boxes. 
Reproduced  from  Molecular  Pathology  of  Thalassaemia  by 
Weatherall  and  Wainscoat  in  Recent  Advances  In 
Haematology  (1985),  with  kind  permission  of  Churchill 
Livingstone,  publishers. chromosome  16,  leaving  one  glubin  gene  on  one  of 
the  pair  and  three  on  the  other  (Figure  6).  A 
3.7  kb  deletion  may  involve  both  a  genes  and  leave 
a  single  composite  a  gene  while  the  other  4.2  kb 
deletion  removes  the  a2  gene. 
2.1 .2  a  thalassaemia  1 
The  common  Southeast  Asian  or  Mediterranean 
a  thalassaemia  1  is  caused  by  different  deletions 
of  the  a-globin  gene  cluster  which  start  downstream 
from  the  a1  globin  genes  (Figure  5)  and  extend 
upstream  through  the  a-globin  chain  gene  cluster, 
removing  the  a2  gene,  the  ~a  gene  and  in  one  case, 
one  of  the  s  globin  genes  (Pressley  et  aI,  1980). 
It  is  not  clear  how  these  deletions  have  arisen. 
They  may  result  from  unequal  crossIng  over  but  the 
reciprocal  arrangements  have  not  been  observed. 
It  is  possible  that  the  major  rearrangements  of 
this  type  are  lethal  (Weatherall  and  Wainscoat,  1985). 
2.2  Non-deletion  Type 
Several  different  "non-deletion"  a  thalassaemia  2 
syndromes  have  been  characterised  (Figure  7)  (Weatherall 
and  Wainscoat,  1985). 
2.2.1  5  bp  Deletion 
This  involves  the  first  intron  of  the  a2  gene 
and  is  characterised  by  abnormal  splicing  of  the 
a2  globin  mRNA.  It  results  from  the  loss  of  five 
bases  (TGAGG)  following  the  G  of  the  invariant  G-T 
contained  within  the  donor  splice  site.  Since, 
almost  without  exception~  intervening  sequences  of 
24 5'  3' 
()(  thai 2  _ 
----------------------------~~  ~~-----------------
3  7  h.b 
ex thai  2 _____________  --i...i _  .....  : _______________ ~ 2  kb 
IX thai 1 
0<  thai 1 
------------~~-
o<:thal1 
-------~~~~ 
----'-'-- :::::::::;:;:;:::::: :;: ;:;:;:;:: 
...............  .................  . 
. :-:':-:-:-:'.-:':-:':-:-:':-:-:-:-:-., 
FIGURE  5:  Th~ different  deletions  responsible  for 
various  forms  of  a  thalassaemia  1  and  a  thalassaemia  2 
Reproduced  from  The  Molecular  Genetics  of  Haemoglobin  -
The  Thalassaemias  by  Weatherall  in  Recent  Advances  in 
Haematology  (1982)  with  kind  permission  of  Churchill 
Livingstone,  publishers. ( i ) 
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FIGURE  6:  Example  of  crossover  between  misaligned 
chromosomes  (ii),  giving  rise  to  (i)  the  -a  haplotype 
and  (iii)  the  aaa- haplotype. 
Reproduced  from  Alpha  Thalassaemia  by  Higgs  and  Weatherall 
in  Current  Topics  in  Haematology  (1983)  with  kind 
permission  of  Alan  R.  Liss,  publishers. functional  genes  have  the  oligonucleotide  GT  at 
/ 
their  5  end, it  has  been  suggested  that  this  small 
deletion,  in  a  critical  region  of  the  gene,  results 
in  failure  of  stable  a2  mRNA  formation  (Figure  8) 
(Felber  et  aI,  1982).  The  5  base  deletion  removes 
a  particular  restriction  site  (HpH  1)  from  the  DNA 
sequence  of  the  a2  gene  and  so  it  can  be  identified 
by  restriction  enzyme  analysis  (Orkin  et  aI,  1981). 
2.2.2  Base  Substitution 
The  second  syndiome  results  from  mutation 
which  produces  a  highly  unstable  a  chain  variant, 
Hb  Quong  Sze,  which  is  rapidly  destroyed  and  hence 
results  in  an  a  thalassaemia  phenotype.  In  this 
case  a  leucine_codon  [Cytosine,  Thymine,  Guanine, 
(CTG)Jin  the  a2-gene  is  changed  to  CCG,  which  codes 
for  proline  (Goossens  et  aI,  1982)  (Figure  8). 
2.2.3  Chain  termination  defects 
Furthermore  non-deletion  a  thalassaemia  can 
result  from  single  base  mutations  in  the  a2  chain 
termination  codon  (Weatherall  and  Clegg,  1975; 
Hunt  et  aI,  1982).  Instead  of  reading  'stop', 
the  point  mutation  allows  an  amino  acid  to  be 
inserted  at  what  is  normally  the  position  of  the 
/ 
stop  codon,  and  then  sequences  at  the 3  end  of  the 
a-globin  mRNA  which  are  not  normally  utilised,  are 
translated.  This  results  in  the  production  of  an 
a  globin  chain  variant  with  31  additional  amino  acid 
residues  at  the  C  terminal  end;  the  prototype  is  Hb 
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FIGURE  7:  A  summary  of  the  different  non-deletion  forms 
of  a  thalassaemia.  (1)  Orkin  et  al  (1981) 
(2)  Goosens  et  al  (1982) 
(3)  Weatherall  and"Clegg  (1975) 
and  (4)  Higgs  et  al  (1983) 
Reproduced  from  Molecular  Pathology  of  Thalassaemia 
by  Weatherall  and  Wainscoat  in  Recent  Advances  In 
Haematology,  with  kind  permission  of  Churchill  Livingstone, 
publishers. Hphl  EcoR II 
31  125 
normal 
Gly  Arg  IVS  Leu 
GAG  AGG  TGAGGCTCCC___  .. _CCCTGGA_. 
:><thalassaemia  Pro 
142 
stop 
_TAA 
Gin 
173 
stOG 
GAG AGG  - ----CTCCC__  .. _CCCCGGA_.  _CAA __  ...... _T:...:-
O(Hph  O(OS  O(CS 
FIGURE  8:  Summary  of  the  molecular  basis  of  "non 
deletion"  (l  thalassaemia  defects.  Non  coding  regions 
are  shown  hatched  exons  by  dark  shading  and  introns  are 
unshaded. 
Reproduced  from  Alpha  Thalassaemia  by  Higgs  and 
Weatherall  in  Current  Topics  in  Haematology  (1983)  wilh 
kind  permission  of  Alan  R.  Liss,  Inc.,  publishers. Constant  Spring  (Figure  8).  Hence  Hb  Constant  Spring 
is  produced  in  very  low  quantities  and  is  associated 
with  the  phenotype  of  a  thalassaemia  2. 
2.2.4  Framesh~ft Deletion 
Recently  a  form  of  a  thalassaemia  2  has  been 
found  in  Eastern  Saudi  Arabian  populations 
(Pressley  et  aI,  1980:  Higgs  et  aI,  1983).  They 
found  that  one  of  the  linked  pair  of  a  globin  genes 
(a1)  has  a  frame-shift  mutation  which  totally 
inactivates  it,  while  the  other  (a2)  has  a  mutation 
in  the  highly  conserved  AATAAA  sequence  in  the  3 
non-coding  region  of  the  a-globin  mRNA  (AATAAA~ 
AATAAG).  This  lesion  reduces  the  output  from  the 
gene. 
3.  DIAGNOSIS  OF  a  THALASSAEMIA  TRAIT 
It  is  very  difficult  to  diagnose  a  thalassaemia  trait 
In  adults,  because  the  disorder  is  asymptomatic  with 
minimal  or  no  blood  changes  (Pornpatkul  et  aI,  1969; 
Weatherall  and  Clegg,  1972;  de  Gruchy  et  aI,  1978). 
Alpha  thalassaemia  2  trait  patients  have  virtually 
normal  blood  pictures;  as  a  group  they  have  only  slightly 
reduced  mean  corpuscular  volume  (MCV)  and  mean  corpuscular 
haemoglobin  (MCH),  with  normal  haemoglobin  A2  and  serum 
ferritin  (Weatherall  and  Wainscoat,  1985).  Unlike 
a  thalassaemia  1,  HbH  inclusions  are  not  demonstrable 
CP 0 r n p a tk  u 1  eta  1,  1 9 7 6;  C  han a r i net aI,  1 9 8 0 ) .  0 n 
the  other  hand  a  thalassaemia  1  patients  show  a 
significant  reduction  in  MCV  and  MCH,  the  peripheral 
26 blood  film  shows  clear-cut  microctyosis  and 
hypochromia;  HbA 2  and  serum  ferritin  levels  are 
normal,  but  HbH  inclusions  are  demonstrable  in 
most  instances. 
3.1  Screening  of  a  thalassaemia  trait  by  red  cell 
measurements 
A  major  diagnostic  difficulty  1S  the  distinction 
of  a  thalassaemia  trait  from  iron  deficiency  using  blood 
counts  only  (Weatherall  and  Clegg,  1981).  There  have 
been  several  attempts  to  differentiate  between  thalassaemia 
trait  and  iron  deficiency  on  the  basis  of  red  blood  count 
measurements.  England  and  Fraser  (1973),  using  a  simple 
"discriminant  function"  (DF)  derived  from  the  mean  cell 
volume  (MCV  in  fl),  the  red  blood  count  (RBC  x  10
6  per 
~l),  and  the  haemoglobin  concentration  (Hb  in  g  per  100  ml). 
DF  MCV  - RBC  - (5  X Hb  )  - 3.4,  claimed  that  a 
positive  value  indicated  iron  deficiency  anaemia  and  a 
negative  value  thalassaemia  trait.  However,  Menzer 
(1973)  suggested  that  an  even  simpler  index,  the  ratio 
MCV/RBC  was  equally  capable  of  distinguishing_  the  two 
conditions;  values  below  13  indicating  thalassaemia 
trait  and  values  greater  than  13  indicating  iron  deficiency 
anaem1a.  Walford  and  Deacon  (1976)  found  these 
formulae  unreliable  when  applied  to  patients  with  1ron 
deficiency  or  thalassaemia  trait.  England  (1979)  in  an 
assessment  study  using  both  formulae  found  that  the 
discriminant  function  was  more  satisfactory  1n 
distinguishing  the  two  conditions,  although  it  was  not 
able  to  distinguish  heterozygous  a  thalassaemia  2  from 
27 Iron  deficiency. 
There  is  also  a  tendency  for  measuring  the 
heterogeneity  of  the  red  cell  volumes  to  differentiate 
iron  deficiency  from  thalassaemia  trait  i.e.  the 
degree  of  anisocytosis.  This  measurement  is  called  the 
Red  Distribution  Width  (ROW)  on  modern  automated  blood 
cell  counters. 
Most  reported  work  on  red  cell  size  distribution 
has  been  carried  out  using  the  Coulter  Counter  Model 
ZB1  with  Channelyzer  C1000  attachment.  Heterogeneity 
of  red  cell  volumes  has  been  variously  expressed  as 
standard  deviation  of  the  natural  logarithms  of  the  red 
cell  volumes,  or  as  a  volume  ratio  for  95%  of  the  cells 
in  the  sample  (volume  of  largest  cell/volume  of  smallest 
cell)  or  as  the  percentage  of  microcytes  (England  and 
Down,  1974).  Alternatively,  Bessman  and  Johnson  (1975) 
have  used  the  co-efficient  of  variation  (CV)  which  is 
the  ratio  of  the  standard  deviation  to  the  mean,  based 
on  a  normal  distribution  (Gaussian).  Both  groups  have 
used  red  cell  volume  analysis  in  the  differentiation 
of  iron  deficiency  from  heterozygous  thalassaemia 
(England  et  aI,  1976;  Bessman,  1980).  In  1979  Bessman 
and  Feinstein  reported  that  the  co-efficient  of  variation 
(CV)  of  the  red  cell  volume  distribution  was  less  than 
14%  in  normal  subjects  and  in  individuals  with  a 
thalassaemia  trait,  but  greater  than  14%  in  patients  with 
iron  deficiency. 
28 3.2  Serum  ferritin  level 
Patients  with  iron  deficiency  anaemia  have  low  serum 
lron  levels  while  those  with  thalassaemia  trait  have 
normal  or  slightly  elevated  levels.  The  diagnostic  value 
of  the  serum  ferritin  level  as  a  function  of  the  amount 
of  storage  iron  in  normal  subjects  and  in  those  with 
iron  deficiency  anaemia  was  described  by  Jacobs  et  al 
(1972).  They  found  that  a  ferritin  level  below  10,ng/ml 
indicated  iron  deficiency.  Hussein  et  al  (1976)  showed 
that  serum  ferritin  was  normal  in  patients  with  S 
thalassaemia  trait,  while  Loria  et  al  (1978)  claimed 
that  all  patients  with  ferritin  above  20  ng/ml  had 
thalassaemia  trait  and  those  below  20  ng/ml  had  iron 
deficiency. 
3.3  Demonstration  of  HbH  inclusion  bodies 
At  birth  the  two  types  of  a  thalassaemia  trait  are 
easily  distinguished.  In  a  thalassaemia  2  trait  the 
levels  of  Hb  8art's  found  range  from  1-3%  (Wasi  et  al, 
1964;  Pootrakul  et  al,  1970).  ·Whereas  in  a  thalassaemia 
1,  levels  of  5-10%  are  detected  (Na-Nakorn  and  Wasi,  1970: 
Weatherall  and  Clegg,  1981).  However,  it  is  very 
difficult  to  diagnose  a  thalassaemia  trait  in  the  adult 
because  low  levels  of  HbH  are  not  detectable  by  starch 
gel  electrophoresis  (Pornpatkul  et  al,  1969;  Weatherall 
and  Clegg,  1972). 
Most  red  cells  In  patients  with  haemoglobin  H 
disease  produce  multiple  rounded  inclusions  which  are 
29 evenly  distributed  throughout  the  cell  when  incubated  with 
redox  dyes  in  vitro  (Gouttas  et  aI,  1955;  Rigas  et  ale 
1 9 5 6;  He den b erg  e  eta  1,  1 9 5 8 ) .  I nth  e irs  t u die  s  G  Clll t t a s 
et  al  (1955)  observed  that  the  inclusions  became 
progressively  more  visible  with  increase  in  incubation 
time  and  increase  in  temperature. 
In  a  thalassaemia  trait,  unlike  haemoglobin  H 
disease,  it is  very  difficult  to  find  the  occasional 
inclusion  bodies  (Pornpatkul  et  aI,  1969;  Weatherall  and 
Clegg,  1972;  Dacie  and  Lewis,  1984). 
There  is  no  agreement  as  to  what  constitutes  the 
best  method  for  demonstration  of  inclusions  in  trait 
subjects.  The  variables  include  redox  dye  used, 
incubation  time  and  temperature.  Various  workers  have 
recommended  the  use  of  1%  brilliant  cresyl  blue  (BCB) 
to  demonstrate  inclusion  bodies  in  trait  patients  using 
an  incubation  temperature  of  37°C  for  periods  varying 
from  10  minutes  to  4  hours  (Dacie  and  Lewis,  1968; 
Schwartz  and  Atwater,  1972;  Walford  and  Deacon,  1976; 
Winichagoon  et  aI,  1980).  On  the  other  hand  Weatherall 
and  Clegg  (1981)  used  BCB  at  25°C  for  two  hours. 
M  0 r ere  c e n t 1 y  a nat  t e m  p t  has  bean  ma d  e  t 0  d e fin e  the 
type  of  trait  in  which  taese  inclusion  bodies  may  be 
found.  Pornpatkul  et  al  (1976)  examined  34  children 
(aged  3-5  years)  for  inclusion  bodies.  These  children 
were  part  of  a  cord  blood  study  (Pootrakul  1970)  and 
hence  their  haematological  data  and  level  of  haemoglobin 
Bart's  at  birth  were  known.  In  addition  the  same  workers 
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Bart's  hydrops  foetalis  syndrome  and  86  individuals 
who  were  parents  of  offspring  with' haemoglobin  H disease. 
They  found  a  very  clear-cut  relationship  between  the 
a  thalassaemia  genotype  and  the  presence  or  absence  of 
inclusion  bodies.  For  example,  nine  of  the  34  children 
had  red  cell  inclusions  and  all  were  desiqnated  as  a 
thalassaemia  1  trait  at  birth.  The  25  who  did  not  have 
inclusions,  were  previously  diagnosed  as  a  thalassaemia 
2  trait  from  their  level  of  Hb  Bart's  at  birth.  All  the 
parents  of  babies  with  the  HBHFS,  who  were  thus 
obligatory  carriers  for  a  thalassaemia  1,  had  red  cell 
inclusion  bodies.  These  studies  suggested  that  HbH 
inclusion  bodies  were  found  mainly  in  a  thalassaemia  1,  but 
that  the  method  was  not  sensitive  enough  to  detect  the 
slight  excess  of  B chains  occurring  in  a  thalassaemia  2. 
3 . 3 . 1  Problems  encountered  in  testing  for  HbH 
inclusion  bodies 
A  positive  test  is  essential  for  the  diagnosis 
of  a  thalassaemia  trait  although  with  existing 
methods  a  negative  result  does  not  exclude  the 
condition.  As  currently  performed,  identification 
of  HbH  inclusions  cannot  be  used  as  a  screening  test 
particularly  so  in  multi-racial  populations  as  In 
the  United  Kingdom  since  the  test  is  usually 
negative  in  Negroes  and  Indians  with  a  thalassaemia 
trait  (Walford  and  Deacon,  1976). 
31 Technical  difficulties  also  occur  which  are  not 
uncommon  depending  on  technique  used.  Thomas  (1966) 
demonstrated  the  formation  of  extensive  spicules 
resembling  HbH  inclusions  in  red  cells  from  normal 
individuals.  He  concluded  that  rough  handling 
induced  the  false  inclusion  bodies.  In  addition, 
false  positive  results  may  be  induced  by  prolonged 
incubation.  Wickramasinghe  et  al  In  1981  reported 
that  normal  red  cells  show  little or  no  ultra-
structural  change  in  their  cell  membranes  after 
supravital  staining  for  up  to  two  hours  at  37°C. 
However  after  24  hours  incubation  red  cells  produced 
inclusions  indistinguishable  from  those  of  HbH. 
Also  Dacie  and  Lewis  (1984)  reported  that  false 
positive  results  could  be  induced  by  incubation  at 
37°C  for  more  than  one  hour. 
3.3.2  Improved  techniques  for  the  demonstration  of 
HbH  inclusions 
In  1973  Raven  and  Tooze  suggested  that  improved 
demonstration  of  HbH  inclusions  in  a  thalassaemia 
trait  could  be  achieved  by  using  a  reticulocyte 
enriched  sample  obtained  by  centrifugation  (Wintrobe 
method).  This  is  so  because  younger  cells  contain 
more  HbH  inclusions  than  older  red  cells  from  the 
same  individual.  Wickramasinghe  et  al  (1981) 
confirmed  this  observation  In  patients  with  HbH 
disease.  However,  Walford  et  al  (1976)  failed  to 
confirm  the  superiority  of  this  centrifugation  method 
over  the  whole  blood  method  for  a  thalassaemia  trait. 
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similar  difficulties  using  the  Wintrobe  method , 
however,  improved  reticulocyte  enrichment  occurred 
when  a  microhaematocrit  technique  was  used.  More 
recently  Maungsapaya  et  al  (1985)  confirmed  this 
observation. 
Pereira  In  1984  reported  that  potassium  iodide 
IS  capable  of  "sensitising"  certain  blue  dyes,e.g. 
methylene  blue  enabling  them  to  precipitate  and  stain 
the  ribonucleic  acid  of  reticulocytes  supravitally  on 
incubation.  With  more  prolonged  incubation  the 
haemoglobin  H  inclusion  bodies  in  a  thalassaemia  can 
also  be  demonstrated. 
3.4  Globin  Chain  Synthesis  Studies 
In  1965  Clegg  et  al  succeeded  in  separating  the  a 
and  non-a  chains  of  human  haemoglobin.  This  technique, 
combined  with  in  vitro  radioactive  labelling  (Weatherall 
et  aI,  1965)  has  now  been  widely  used  to  study  haemoglobin 
synthesis  In  the  cells  of  patients  with  a  thalassaemia 
syndrome.  The  first  studies  of  this  kind  were  reported  by 
Kan  et  al  (1968)  and  Schwartz  et  al  (1969)  who  examined 
relatives  of  infants  with  Hb  8art's  hydrops  foetal is 
syndrome  and haemoglobin  H  disease.  They  measured  the 
a/S  globin  chain  synthesis  ratios  in  an  attempt  to 
classify  them  into  four  different  groups,  i.e.  normal, 
a  thalassaemia  2,  a  thalassaemia  1  and  haemoglobin  H 
disease.  They  reported  that,  while  there  is  a  significant 
33 reduction  in  a  chain  synthesis  in  certain  forms  of 
a  thalassaemia,  overlap  occurred  between  a  thalassaemia 
2  and  a  thalassaemia  1,  and  between  a  thalassaemia  2  and 
normal  individuals.  Other  workers  seem  to  have  been 
slightly  more  successful  in  their  attempts  to  separate 
the  differ~nt forms  of  a  thalassaemia  by  globin  chain 
synthesis  studies.  For  example,  Pootrakul  et  al  (1975a) 
examined  haemoglobin  synthesis  in  28  obligatory  carriers 
of  a  thalassaemia.  Tnese parents  of  babies  with  the 
haemoglobin  Bart's  hydrops  foetalis  syndrome,  were  found 
to  have  a/S  globin  chain  synthesis  ratios  of  0.76±  0.04. 
The  parents  of  patients  with  haemoglobin  H disease  were 
found  to  fall  into  two  clear  groups:  one  with  a  mean 
a/S  ratio  of  0.78  ±  0.03;  the  other  with  a  ratio  of 
0.92  ±  0.03  (control  range  1.0  - 1.2). 
Walford  and  Deacon  (1976)  used  globin  chain  synthesis 
studies  to  confirm  the  disorder  in  random  patients 
suspected  to  have  a  thalassaemia  trait  because  of 
abnormalities  in  their  red  cell  indices.  While, in  64 
subjects  studied  (44  patients,  20  controls), no  numerical 
overlap  of  results  between  the  groups  was  detected  1.e. 
control  and  a  thalassaemia  trait,  the  results  were  so 
close  that  in  a  larger  series  some  degree  of  overlap 
might  reasonably  be  anticipated.  It  was  not  possible  to 
subdivide  trait  patients  from  this  data. 
Weatherall  and  Clegg  (1981)  concluded  that  many 
heterozygous  a  thalassaemia  subjects  have  a  significant 
reduction  in  a/S  globin  chain  synthesis,  although  in 
some  cases  of  a  thalassaemia  2  the  diagnosis  can  only  be 
34 suspected  by  this  technique  and  requires  confirmation 
by  gene  mapping. 
4.  ALPHA  THALASSAEMIA  IN  DIFFERENT  RACIAL  GROUPS 
Alpha  thalassaemia  syndromes  constitute  an 
heterogenous  group  of  disorders  with  wide  geographical 
distribution  being  particularly  prevalent  in  Southeast~ 
Asia,  the  Mediterranean,  the  Middle  East,  parts  of  the 
African  continent  and  in  India.  Recently  it  has  been 
described  in  persons  of  North  European  origin.  Clearly, 
it is  also  found  in  Asian,  Negro,  Mediterranean  and  Indian 
subcontinent  emigrant  populations  worldwide. 
4.1  Alpha  Thalassaemia  in  Oriental  Races 
The  disorder  is  most  common  in  Southeast  Asia 
(Na-Nakorn  et  aI,  1956:  Lie-Injo  et  aI,  1957;  Flatz 
et  aI,  1965;  Wasi  et  aI,  1967; 
Na-Nakorn  et  aI,  1969;  Pooirakul 
Pootrakul  et  aI,  1967; 
et  aI,  1975b) with  a 
very  high  incidence  in  Northern  Thailand  (Thumasathit  et 
aI,  1968;  Na-Nakorn  and  Wasi,  1970).  Twenty  seven  cases 
of  Hb  Bart's  hydrops  foetalis  were  reported  in  a  period 
of  two  years  at  Chiengma  (Thumasathit  et  aI,  1968)  where 
an  incidence  of  30.7%  at  birth  have  elevated  levels  of 
H  b  Bart's  (N a - N  a k 0 rna  n d  Wa s i,  1970).  Based  on  this 
incidence  of  Hb  Bart's  at  birth,  these  workers  estimated 
a  frequency  of  a  thalassaemia  2  of  17.4%,  a  thalassaemia 
1  of  12.2%,  and  an  incidence  of  HbH  disease  in 
approximately  1%  of  the  population.  Based  on  these 
frequencies  the  haemoglobin  Bart's  hydrops  foetalis 
syndrome  is  expected  to  occur  with  a  frequency  of  about 
0.4%. 
35 A  high  incidence  of  a  thalassaemia  has  also  been 
reported  in  other  parts  of  Southeast  Asia.  Cord  blood 
surveys  have  shown  that  3-4%  of  Chinese  infants  living 
In  other  parts  of  Southeast  ASia,  have  increa?ed  levels 
of  Hb  Bart's  (Vella,  1959:  Lie-Injo,  1959:  Todd  et  aI, 
1969:  Wong,  1970).  Alpha  thalassaemia  is  well 
documented  in  Chinese  populations  who  have  moved  from 
Southeast  Asia.  Gray  and  Marion  (1971)  found  a  6.7% 
incidence  of  a  thalassaemia  trait  in  Chinese  persons 
living  in  Candda.  Haemoglobin  H  disease  is  well 
recognised  in  Chinese  immigrants  in  the  USA,  UK  and 
Caribbean  (Weatherall  and  Clegg,  1981).  In  1976 
Walford  and  Deacon  studied  adult  Chinese  immigrants 
in  the  UK  with  a  thalassaemia  trait,  but  they  could 
not  differentiate  them  into  a  thalassaemia  2  and  a 
thalassaemia  1.  The  same  observation  was  reported  by 
Todd  and  Chan  (1978)  who  examined  the  levels  of 
haemoglobin  Bart's  in  infants  born  to  mothers  with 
haemoglobin  H  disease. 
Generally  the  four  types  of  a  thalassaemia  I.e. 
a  thalassaemia  2,  a  thalassaemia  1,  HbH  disease  and 
Hb  Bart's  hydrops  foetalis  syndrome  occur  frequently  In 
oriental  populations  with  deletion  genotypes  (-a/aa), 
(--/aa),  (--I-a)  and  (--1--)  respectively.  However, 
non-deletion  forms  of  a  thalassaemia  are  very  rare  In 
this  population  (Weatherall  and  Clegg,  1981). 
4.2  Alpha  Thalassaemia  in  Mediterranean  Races 
Although  previously  thought  to  be  rare,  more  recent 
evidence  suggests  that  a  thalassaemia  does  cccur  not 
36 infrequently  In  certain  Mediterranean  areas!  notably 
Sardinia  and  Cyprus  (Weatherall  and  Clegg,  1981). 
Elevated  levels  of  Hb  Bart's  were  found  in  4.3%  of  new 
born  infants  in  Northern  Sardinia  (Bianco  et  aI,  1972). 
In  1979,  Hadjaminas  et  al  found  that  of  1200  Greek 
Cypriot  and  132  Turkish  Cypriot  newborns  12.4%  and 
6.8%  respectively  had  elevated  levels  of  haemoglobin 
Bart's. 
The  genetic  and  the  haematological  features  of 
a  thalassaemia  trait  are  similar  to  those  observed  in 
oriental  races  (Weatherall  and  Clegg,  1981).  Although 
the  surveys  thus  far  are  limited,  it  would  appear  that 
the  non  deletion  form  of  the  disea~e  occurs  more  commonly 
in  these  Mediterranean  popualtions  than  in  those  of  South 
East  Asia  (Weatherall  and  Wainscoat,  1985). 
4.3  Alpha  Thalassaemia  in  Negroes 
Recent  studies  in  African  Negro  populations  suggest 
that  approximately  3%  of  African  infants  have  elevated 
levels  of  Hb  Bart's  ranging  from  3  - 10%  (Weatherall  and 
Clegg,  1981).  A  similar  incidence  was  observed  in  Negro 
infants  in  Jamaica  and  the  USA.  However,  there  have  been 
very  few  attempts  to  estimate  the  frequency  of  a 
thalassaemia  in  the  adult  Negro  populations.  Pierce  et  al 
(1977)  assessed  the  frequency  of  a  thalassaemia  in  the 
American  Negro  using  globin  synthesis  studies.  They 
suggested  that  about  5%  of  adult  Negroes  possessed 
haematological  and  globin  chain  synthesis  ratios  comparable 
with  those  in  a  thalassaemia  1  in  oriental  races. 
2.5%  of  this  population  was  classified  as  a 
thalassaemia  2.  Using  globin  gene  mapping 
37 Dozy  et  81  (1979)  and  Higgs  et  al  (1980)  showed  that 
about  3%  of  the  Negro  population  were  homozygous  for 
a  thalassaemia  2  and  about  25%  heterozygous  for  this 
determinant. 
It  had  been  suggested  that  the  genetic  and 
possibly  the  molecular  basis  of  Negro  a  thalassaemia 
may  differ  from  those  of  the  oriental  or  the 
Mediterranean  races,  because  the  disorder  is  relatively 
milder  in  Negroes  (Weatherall  and  Clegg,  1972).  This 
was  confirmed  by  Schwartz  and  Atwater(1972a)  who  reported 
that  the  genetic  basis  of  a  thalassaemia  trait  in  the 
American  Negro  differs  from  other  racial  groups.  They 
thought  that  there  may  be  only  one  gene  deletion 
(-a/aa),i.e.  only  a  thalassaemia  2,in  this  group.  That 
idea  was  also  supported  by  Wasi  et  al  (1974).  They 
claimed  that  a  thalassaemia  in  the  Negro  and  non-Asian 
groups  may  not  be  identical  with  a  thalassaemia  2  and 
a  thalassaemia  1.  Howeve~,  Higgs  et  al  (1979)  and  Dozy 
et  al  (1979)  unlike  the  previous  studies  found  the  two 
forms  of  a  thalassaemia  trait  in  some  Negro  populations. 
Using  gene  mapping  studies,  they  discovered  that  the 
mild  forms,i.e.  a  thalassaemia  2,resulted  from  the 
deletion  of  one  a  gene  (-a/aa)  while  the  severe  form, 
which  resembled  a  thalassaemia  1,  lS  in  fact  the 
homozygous  form  of  a  thalassaemia  2  with  genotype 
(-a/-a).  The  genotype  (--/aa)  is  very  rare  in  Negroes 
(Figure  9).  These  studies  explain  the  rare  occurrence 
of  HbH  disease  and  the  complete  absence  of  HbBHF  syndrome 
in  Negroes. 
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FIGURE  9:  Comparison  of  homozygous  a  thalassaemia  2 
in  Negroes  with  heterozygous  a  thalassaemia  in 
Orientals.  (open  boxes  indicate  normal  genes  and 
shaded  boxes  deleted  genes). A  more  detailed  ~nalysis  of  Negro  a  thalassaemia  2 
haplotype  has  been  carried  out  by  Higgs  et  al  (1980). 
These  experiments  have  shown  that  it  has  probably  arisen 
by  gene  deletion  (-a)  as  is  found  In  oriental  races. 
4.4  Alpha  Thalassaemia  in  India 
There  is  very  limited  information  on  the  incidence  of 
and  _  molecular  defects  in  a  thalassaemia  in  Indians 
(Weatherall  and  Clegg,  1981). 
Early  studies  on  the  incidence  of  the  disorder  in 
infants  suggested  that  about  1%  of  newborn  Indian  infants 
in  Singapore  or  Malaysia  have  elevated  levels  of 
haemoglobin  Bart's  (Vella,  1959;  Lie-Injo  and  Ti,  1961). 
Chauhan  et  al  (1970)  found  elevated  levels  in  4%  of 
Bengali  infants  and  in  1%  of  Maharashtrians.  There  are 
no  reports  of  HbBHF  syndrome  in  the  Indian  population. 
There  have  been  sporadic  reports  of  a  thalassaemia 
In  the  adult.  Chatterjea  (1959)  and  Swarup  et  al  (1963) 
described  cases  of  HbH  disease  in  single  Indian  families 
and  further  reports  of  HbH  disease  are  reviewed  by  Saha 
and  Banerjee  (1973).  However,  the  genetic  basis  of 
HbH  disease  in  India  is  unknown  (Weatherall  and  Clegg, 
1981).  The  heterozygous  state  for  a  thalassaemia  in 
adult  Indians  has  only  been  reported  once  by  Walford  and 
Deacon  (1976).  They  found  that  a  thalassaemia  trait  IS 
a  common  disorder  in  Indian  immigrant  populations  in  the 
UK  with  less  striking  changes  in  the  red  cell  indices 
when  compared  to  that  _ of  Oriental  trait  subjects  (Chinese). 
39 They  were  unable  to  distinguish  two  clear  cut  varieties 
of  a  thalassaemia  trait  in  this  population.  They 
proposed  that  the  genetic  defect  in  Indian  a  thalassaemia 
trait  is  the  same  as  that  In  Oriental  a  thalassaemia  2 
i.e.  -a/aa.  On  this  genetic  model,  they  thought  that 
the  homozygous  form  (-a/-a)  would  result  in  a  50% 
deficit  in  a  chain  production  and  would  thus  resemble 
in  severity  oriental  a  thalassaemia  1  trait  (as  found 
recently  In  Negroes).  So  far  no  such  Indian  homozygote 
has  been  identified. 
4.5  Alpha  Thalassaemia  In  the  Middle  East 
Alpha  thalassaemia  has  been  reported  in  many  Middle 
Eastern  populations  although  there  is  a  limited  amount 
of  information  about  true  gene  frequencies  (Weatherall 
and  Clegg,  1981). 
One  of  the  first  reports  of  a  thalassaemia  in 
Israel  was  that  of  Ramat  and  her  colleagues  (1959)  who 
described  a  form  of  haemoglobin  H  disease  with 
persistence  of  high  levels  of  haemoglobin  Bart's  In  an 
oriental  Jewess.  In  a  survey  of  newborn  infants  In 
Israel,  Goldschmidt  et  al  (1968)  reported  an  incidence  of 
1.3%  for  increased  amounts  of  haemoglobin  Bart's. 
Affected  infants  had  morphological  changes  suggestive  of 
a  thalassaemia. 
The  incidence  and  distribution  of  a  thalassaemia 
In  Israel  have  been  studied  more  extensively  over  the 
last  few  years.  The  disorder  appears  to  be  confined 
mainly  to  Yemenite  and  Iraqi  Jewish  communities. 
40 Increased  levels  of  haemoglobin  Bart's  have  been  found 
in  cord  bloods  in  17%  of  Yemenite  and  11%  of  Iraqi 
newborn  infants  (Zaizov  and  Natoth,  1972).  Furthermore, 
haemoglobin  H  disease  is  not  uncommon  in  these  Jewish 
communities.  The  genetics  of  a  thalassaemia  in  these 
populations  was  studied  by  Zaizov  et  aI,  1972;  1973. 
Based  on  haematological  and  globin  synthesis  studies,  these 
authors  were  not  able  to  demonstrate  the  presence  of  two 
clear  a  thalassaemia  phenotypes  in  these  families.  They 
favoured  an  inheritance  of  a  thalassaemia  through  a  single 
mutant  gene  with  variable  expressivity  in  these 
populations.  Recently  both  deletion  and  non-deletion 
forms  of  a  thalassaemia  have  been  found  in  patients  with 
haemoglobin  H  disease  from  Israel  (Weatherall  and  Clegg, 
1981). 
Surveys  of  newborn  infants  in  the  eastern  oases 
populations  of  Saudi  Arabia  have  shown  one  of  the 
highest  incidences  for  increased  levels  of  haemoglobin 
Bart's  found  anywhere  in  the  world  (Pembury  et  aI,  1975). 
They  found  elevated  levels  of  haemoglobin  Bart's  ranging 
from  1  to  16%  in  50%  of  newborn  infants. 
Although  haemoglobin  H  disease  has  been  reported  In 
the  oases  populations,  it is  relatively  rare  and 
haemoglobin  Bart's  hydrops  foetalis  has  not  been  observed 
(Weatherall  and  Clegg,  1981).  McNiel  (1971)  reported 
family  studies  on  haemoglobin  H  disease  in  this  population 
and  came  to  the  conclusion  that  the  disorder,  unlike  that 
of  Oriental  or  Mediterranean  types,  results  from  the 
interaction  of  two  a  thalassaemia  genes  which  were  not 
41 clinically  or  haen,atologically  distinguishable.  More 
recently  in  1980,  Pressley  et  al  supported  McNiel's 
conclusion  of  the  presence  of  two  identical  a  thalassaemia 
genes  in  HbH  disease.  From  a  combination  of  haematological, 
globin  chain  synthesis,  mRNA  and  gene  mapping  studies, 
they  showed  that  both  deletion  (-a)  and  non-deletion 
T 
(aa  )  haplotypes  are  present  in  the  Saudi  population. 
However,  individuals  with  haemoglobin  H disease  had 
normal  gene  maps  and  family  studies  proved  that  they 
had  a  normal  complement  of  four  a  chain  genes  and  they 
were,in  fact,homozygous  for  a  non-deletion  defect 
They  suggested  that  the  expressed  phenotype 
of  non-deletion  a  thalassaemia  gene  present  in  this 
population  was  intermediate  between  those  of  the  Oriental 
a  thalassaemia  1  and  a  thalassaemia  2  deletion  genes. 
Also  from  those  studies  they  suggested  that  the  genotype 
(--/aa),i.e.  a  thalassaemia  1,may  be  extremely  rare  in 
Saudi  Arabia  which  could  explain  the  absence  of  HbBHFS 
there. 
4.6  Alpha  Thalassaemia  in  North  Europeans 
Alpha  thalassaemia  seems  to  be  relatively  uncommon 
In  North  European  races.  In  small  cord  blood  surveys 
elevated  levels  of  haemoglobin  Bart's  have  not  been 
observed  (Vella,  1959;  Weatherall,  1963)  and  there  have 
only  been  sporadic  reports  of  the  occurrence  of  HbH 
disease  (Hedenburg  et  aI,  1958;  Woodrow  et  aI,  1964). 
During  their  studies  on  single  Swedish  and  English 
families,  they  noted  that  the  haematological  findings 
42 were  similar  to  those  In  oriental  families. 
There  IS  no  doubt  that  forms  of  a  thalassaemia 
trait  do  occur  occasionally  in  North  European  populations 
(Weatherall  and  Clegg,  1981).  Such  patients  have  had 
thalassaemia-like  blood  pictures  with  normal  levels  of 
HbA Z  and HbF;  a/S  globin  chain  synthesis  ratios  however 
showed  unequivocal  evidence  of  a  thalassaemia  although 
precisely  which  category  these  cases  fall  into  is  not 
known. 
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1.  SAMPLE  POPULATION 
1.1  Controls 
Twenty  healthy  adult  volunteers  aged  18-72  years 
(10  males  and  10  females)  were  chosen  as  normal 
controls. 
1.2  Patients 
After  informed  consent  32  patients  were  selected 
because  of  abnormality  in  their  red  cell  measurements. 
Patients  were  suspected  to  possess  a-thalassemia 
trait  when  all  the  following  abnormalities  were 
present  (Weatherall  and  Clegg,  1972;  Pearson  et  aI, 
1973;  Carrell  and  Lehmann,  1983);-
(a)  Mean  corpuscular  volume  (MCV)  less  than  80  fl. 
(b)  Mean  corpuscular  haemoglobin  (MCH)  less  than 
( c ) 
( d ) 
( e ) 
( f) 
( g ) 
( h ) 
27  pg. 
1 2  Red  cell  count  (RBC)  greater  than  4  x  10  II. 
Haemoglobin  concentration  10  gldl  or  greater 
Normal  haemoglobin  electrophoresis 
Normal  HbF  percentage  (HbF  <  1%) 
Nor mal  H  b A  2  per  c e n tag  e  (H b A  2  <  3 . 3?n 
Normal  serum  ferritin. 
In  addition  the  red  cell  volume  distribution 
(red  distribution  width  [ROW])  was  assessed  to  see 
if it  was  suitable  for  use  as  a  screening  test  to 
differentiate  between  iron  deficiency  and  a-
thalassaemia  trait. 
45 2.  SAMPLING 
30  ml  of  venous  blood  was  withdrawn  from  each  patient 
and  control  subject  following  venous  occlusion  using  a 
syrInge  and  needle  of  bore  size  19-5WG.  All  sampling  was 
carried  out  between  9.00  a.m.-11  a.m.  A  10  ml  aliquot 
of  blood  was  anticoagulated  in  dipotassium  ethylene-
diaminetetra-acetic  acid  (K 2EDTA)  to  give  a  final  concentration 
of  1.5  mg/ml  for  routine  blood  counts,  HbH  inclusion 
demonstration  and  serum  ferritin  estimation.  The 
remainder  of  the  original  sample  (20  ml)  was 
anticoagulated  with  Lithium  heparin  (LH)  at  a  final 
concentration  of  15±  2.5  I.U./ml  for  globin  chain  synthesis 
studies. 
All  investigations  were  commenced  within  one  hour  of 
sample  collection  with  the  exception  of  ferritin  where 
the  plasma  was  separated  immediately  and  kept  frozen  at 
_20DC  for  batch  analysis. 
3.  RED  CELL  MEASUREMENTS 
3.1  Principle 
Blood  counts  were  performed  on  an  aperture 
impedance  counter  (Coulter  Counter  Model  S  Plus  IV). 
The  haemoglobin  was  measured  by  the cyanmethaemglobin, 
method. 
3.2  Method 
The  following  parameters  were  measured:  red 
blood  cell  count  (RBC  x  1012/1),  haemoglobin 
con c e n t rat ion  (H G  Bg I d 1 ),  h a e mat 0 c r i t  (H C  T  1 I 1 ) 
mean  corpuscular  volume  (MCV  fl),  mean  corpuscular 
46 haemoglobin  (MCH  pg),  mean  corpuscular  haemoglobin 
concentration  (MCHC  gidl)  and  the  new  parameter ,red 
distribution  width  (RDW%). 
Red  Distribution  Width 
The  ROW  is  a  sensitive  electronic  measurement 
of  red  cell  anisocytosis  i.e.  an  expression  of  the 
volume  distribution  of  the  erythrocyte  population. 
It  is  computed  from  the  RBC  volume  histogram. 
Calculation  of  ROW 
The  red  cells  are  counted  and  then  channelysed 
using  three  pulse  height  analysers  each  of  256 
channels.  A total  of  75,000  cells  may  be  accumulated 
i~  up  to  five  count  periods  to  generate  a 
representative  volume  distribution  histogram. 
A  ;partitle  of  volume  range  36-360  fl 
IS  classed  as  a  red  cell.  The  mean  cell  volume  IS 
obtained  from  this  distribution  by  Simpson's 
integration,  a  new  method  for  MCV  determination.  The 
method  of  ROW  calculation  is  also  new  and  the  way  in 
which  this  measurement  is  generated  is  shown  in 
Figure  10.  From  any  volume  distribution  histogram  the 
volume  data  below  20%  of  scale  IS  excluded  and  the 
co-efficient  of  variation  (CV)  of  the  remainder  of 
the  distribution  calculation  using  the  16th  and  84th 
percentile  volumes  which  are  obtained  from  a 
continuously  variable  threshold  circuit.  The 
threshold  which  commences  at  a  level  equivalent  to 
360  fl  is  moved  progressively  lower until  16%  of  all 
cells  present  have  passed  the  threshold.  The  cell 
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FIGURE  10:  Describes  the  principles  used  to  calculate 
the  ROW  on  the  Coulter  ModelS  Plus  II  and  all  subsequent 
models. 
Reproduced  by  kind  permission  of  Coulter  Electronics  Ltd. size  at  which  this  event  occurs  IS  recorded  as  the 
16th  percentile  volume.  The  threshold  continues  to 
move  downwards  until  84%  of  the  cells  present  have 
passed.  The  cell  size  at  which  this  event  occurs  is 
recorded  as  the  84th  percentile  volume.  The  data 
truncation  before  the  calculation  of  CV  is  to  exclude 
possible  interference  due  to  electrical  nOIse  and 
debris  at  the  lower  end  of  the  red  cell  SIze 
distribution - The  CV  of  the  trunc8ted  distribution  IS 
then  sC8led  up  by  8  f8ctor  of  1.15  to  compensate  for 
the ·excluded  d8t8  8nd  this  modified  CV  is  called  the 
RDW  (Rowan,  1983). 
4.  HAEMOGLOSINOPATHY  INVESTIGATIONS 
The  blood  sample  was  washed  three  times  In  normal 
saline.  After  each  wash  the  sample  was  centrifuged  at 
1170  g  for  5  minutes.  An  equal  volume  of  distilled  water 
was  added  to  the  cells  together  with  6  drops  of  toluene 
[SOH].  The  haemolysate  thus  produced  was  mixed  on  a 
mechanical  shaker  for  10  minutes  and  then  centrifuged 
for  a  further  10  minutes.  The  haemolysate  was  then 
filtered  using  a  Whatman 
haemoglobin  concentration 
filter  paper 
adjusted 
4.1  Haemoglobin  electrophoresis 
4.1  Principle 
No. 
to 
1 
5 
and  the 
mg/dl. 
Haemoglobin,  like  all  proteins,  has  a  buffering 
potenti81.  The  iso-electric  point  of  8  protein  is 
48 the  pH  at  which  the  total  charges  carried  cancel  out 
resulting  ln  neutrality.  At  a  pH  alkaline  to  the 
iso-electric  point,  the  protein  or  haemoglobin  is 
negatively  charged  and  moves  to  the  positive  electrode 
(anode)  on  electrophoresis.  The  opposite  occurs  at 
acid  pH  where  positively  charged  material  moves  to  the 
negative  electrode  (~athode)  [Lehmann  and  Huntsman, 
1974J. 
4.1 .2 Material 
The  following  instruments  and  reagents  were 
provided  by  Helena  Laboratories  (Beaumont,  Texas, 
U.S.A.):-
Instruments 
Titan  electrophoresis  chamber 
Titan  power  supply 
Micro  dispenser 
Applicator 
Stain"ing  rack 
Aligning  base 
Reagents 
14.6  g  Tris  Borate  EDTA  buffer 
(Supre  Heme  dissolved  in  980  ~l  H20) 
Titan  111-H  Cellulose  acetate  plate  (76  x  60  mm) 
0.5%  (W/V)  Ponceau  5  stain. 
4.1.3  Method 
100  ml  of  Tris  buffer  (pH  8.6)  was  added  to  each 
of  the  outer  compartments  of  the  electrophoresis 
49 chamber.  The  cellulose  acetate  plates  were  soaked  in 
buffer,  gently  blo~ted  and  placed  on  an  aligning  base, 
cellulose  acetate  side  up  and  application  point  25  mm 
from  the  cathode.  Using  the  microdispenser,  each  well 
in  the  sample  plate  was  filled  with  5  ~l  of  the 
haemolysate.  An  applicator  was  then  loaded  by  depressing 
the  tips  into  the  sample  well  several  times.  The 
loaded  applicator  was  then  applied  to  the  wet  plates, 
the  latter  being  very  quickly  placed  in  the  electro-
phoresis  chamber,  cellulose  acetate  side  down,  and 
point  of  application  nearest  to  the  cathode.  Electro-
phoresis  was  carried  out  for  25  minutes  at  a  potential 
of  350  volts  across  the  strip.  The  strips  were  then 
stained  by  Ponceau  S  for  5  minutes  and  washed  three 
times  in  5%  acetic  acid  (BDH)  each  for  2  minutes,  to 
remove  excess  stain,  and  finally  left  to  dry. 
4.2  HbF  Estimation  by  Alkali  Denaturation  Method 
4 • 2 . 1  Principle 
Measurement  of  the  total  foetal  haemoglobin 
1S  dependent  on  the  y  chain  lacking  an  internal 
cysteine  residue  which  is  present  in  the  S globin 
chain.  This  cysteine  residue  in  the  S globin  chain  1S 
ionised  causing  instability  and  precipitation.  The  y 
chain  on  the  other  hand,  is  stable  at  alkaline  pH 
and  is  therefore  described  as  alkali-resistant. 
Sodium  hydroxide  (NaOH)  is  used  to  denature 
adult  haemoglobin  (HbA)  which  is  then  readily 
precipitated  by  ammonium  sulphate  [(NH4 )2  S04J· 
50 4.2.2  Method 
HbF  was  measured  by  the  method  described  by 
Singer,  Chernoff  and  Singer  (1951)  modified  by  Went 
and  MacIver  (1961). 
The  haemolysate  (0.2  ml)  was  added  to  3.2  ml  of 
IN 
N/12  NaoH  (33.3  ml'NaoH  made  up  to  400  ml  with 
distilled  water). 
At  precisely  60  seconds,  6.8  ml  of  acidified 
ammonium  sulphate  (152  gm  ammonium  sulphate  dissolved 
in  400  ml  distilled  water  and  1  ml  of  10N  .HCl)  was 
added,  mixed, allowed  to  stand  for  one  minute  and  then 
filtered  using  Whatman  No.50  filter  paper. 
The  optical  density  (00)  of  the  filtrate  (HbF) 
was  then  measured  spectrophotometrically  at  540  nm. 
To  determine  the  optical  density  of  100%  haemoglobin, 
0.1  ml  of  the  haemolysate  was  added  to  10  ml  of 
ammoniated  water  (0.2  ml  ammonia  solution  [specific 
gravity  0.85J  made  up  to  500ml  with  distilled 
water)  mixed  and  measured  exactly  as  the  filtrate. 
The  percentage  of  HbF  was  then  calculated  using 
the  following  equation:-
00  of  HbF 
%  HbF  x  100 
00  of  100%  Hb  x  2 
5 1 4.3  Estimation  of  HbA 2  by  micro-column  method 
4.3.1  Principle 
HbA 2  is  selectively  eluted  from  a  chromato-
graphic  column  under  specified  conditions  of  pH 
and  chloride  ion  concentration. 
4.3.2  Method 
HbA 2  was  measured  by  the  micro-column  method 
described  by  Huisman  et  al  (1975)  and  Abraham  et 
al  (1976  - 1977)  using  HbA 2  test  kits  (Isolab  Inc.) 
which  include  all  reagents  and  columns. 
50  ).11  of  the  haemolysate  (prepared  as  above)  was  loaded 
on  to  the  surface  of  a  preconditioned  DEAE-cellulose 
column  bed.  Any  residual  sample  adhering  to  the 
walls  of  the  column  was  carefully  washed  on  with 
200  ).11  of  the  HbA 2  elution  agent  and  the  eluate 
discarded.  The  HbA 2  fraction  was  eluted  by  a  further 
4  ml  of  elution  agent  and  the  eluate  retained  for 
analysis.  To  elute  the  other  haemoglobin  fractions 
(HbA  and  HbF),  4  ml  of  a  second  elution  agent  was 
added  and  the  eluate  diluted  with  16  ml  of  distilled 
water.  The  absorbance  values  of  the  two  fractions 
were  measured  spectrophotometrically  at  540  nm. 
Estimation  of  HbA 2  percentage  was  carried  out  as 
follows:-
100X 
x  +  5Y 
where  x  Absorbance  of  HbA 2  fraction 
Y  - Absorbance  of  "other  haemoglobin" 
fraction 
52 5.  SERUM  FERRITIN  BY  RADIOIMMUNOASSAY  (RIA) 
5.1  Principle 
The  assay  employs  constant  amounts  of  two 
pre-mixed  antibodies,  one  (goat  anti-human  ferritin) 
covalently  bonded  to  glass  particles  and  the  second 
(rabbit  ferritin  antibody)  radio-iodinated  and  free  In 
solution.  A  variable  amount  of  antigen  is  provided 
by  the  patient  samples.  The  ferritin  antibody  bonded 
to  the  glass  particles  will  bind  to  any  ferritin 
present  and  forms  a  solid  phase  complex  to  which  the 
second  tracer  antibody  binds.  The  solid  phase  complex 
is  separated  by  centrifugation  and  counted  for  radio-
activity.  The  amount  of  labelled  antibody  IS 
proportional  to  the  serum  ferritin  concentration  and 
calculated  from  a  standard  curve  (Figure  11). 
5.2  Method 
The  method  of  Addison  et  al  (1972)  was  used 
(Corning,  Immunophase  Ferritin  [125IJ  RIA  kits). 
Seven  standards  (included  in  kits)  of  known 
ferritin  concentrations  are  arranged  in  ascending 
order  of  concentration  (0-1000  ng/ml)  and  used  to 
plot  a  standard  curve.  Also  two  controls  with  ferritin 
concentration  in  the  normal  and  the  low  range  are 
provided  for  internal  quality  control  purposes. 
50  ~l  aliquots  from  each  of  the  standards, 
controls  and  patients  were  placed  into  appropriately 
labelled  test  tubes  (12  x  75  mm)  in  duplicate.  500~1 
of  antibody  slurry  was  added  to  each  tube  and  mixed 
for  4  seconds.  All  tubes  were  then  incubated  for 
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Fig.  11  Standard  curve  of  serum  ferritin. 30  minutes  at  room  temperature.  To  each  tube  500  ~l 
of  [125 IJ  ferritin  antibody  was  added,  mixed  for  a 
further  4  seconds  and  finally  incubated  for  two  hours 
at  room  temperature.  2  ml  of  distilled  water  was  then 
added  to  each  tube  followed  by  centrifugation  at  1170 
g  for  10  minutes.  The  tubes  were  decanted  and  counted 
in  an  L.K.B.  Gamma  Counter. 
6.  DEMONSTRATION  OF  HbH  INCLUSIONS 
6.1  Principle 
Incubation  of  red  blood  cells  with  a  redox  dye 
such  as  brilliant  cresyl  blue  (BCB)  causes  oxidative 
denaturation  and  precipitation  of  unstable  haemoglobin 
H(S4)  resulting  in  diffuse  stippling  of  the  red  cell 
(Figure  12).[Schwartz  and  Atwater,  1972bJ. 
6.2  Method 
6.2~1  Routine  Method 
Equal  volumes  of  1%  BCB  (Gurr)  and  blood  were 
incubated  at  25°C  for  24  hours,  after  which 
blood  smears  were  prepared. 
6.2.2  Experimental  Methods 
6.2.2.1  whole  blood  method: 
To  see  if the  HbH  test  could  be  improved  in  the 
laboratory,  changes  were  made  in  incubation 
temperature;  variation  in  incubation  time  and 
finally,  the  effect  of  the  addition  of 
potassium  iodide  as  a  stimulant. 
54 FIGURE  12:  HbH  inclusion  bodies  in  blood  of  patient 
with  HbH  disease. For  each  patient  and  each  control  four  tubes 
(75  x  10  mm)  were  labelled  as  in  Table  I. 
1st  2nd  3rd  4th 
Blood  volume  (drop)  3  3  3  3 
1  01 
10  BCB  volume  (drop)  3  3 
Incubation 
temperature  (  a C )  25  37  25  37 
* 1  ~~  BCB-KI  volume 
(drop)  3  3 
TABLE  I:  Whole  blood  method  varying  temperature  with 
and  without  potassium  iodide. 
*1  gm  BCB/100  ml  KI. 
Potassium  iodide  (BDH)  IS  dissolved  in  the  proportion  of 
1  mg/ml  in  citrate-saline  solution  (one  part  3  gm/100  ml 
sodium  citrate  [BDH]  to  four  parts  normal  saline). 
The  tubes  were  incubated  at  25°C  and  37°C  for  10, 
20,  30  and  60  minutes,  2,  3,  4  and  5  hours  and  thereafter 
dry  blood  smears  were  prepared. 
6.2.2.2  Centrifuged  blood  method 
This  technique  was  performed  to  determine  any 
advantage  over  the  whole  blood  method. 
The  Wintrobe  tubes  (2.5  mm  x  100  mm)  were  filled  with 
KEOTA  blood  to  provide  sufficient  packed  red  cells 
2 
for  subsequent  experimentation  (Raven  and  Tooze, 
1973).  These  were  centrifuged  at  4500  g  for  10 
minutes.  One  drop  from  each  Wintrobe  tube,  at 
approximately  3  mm  above  and  5  mm  below  the  plasma-
cell  interface  (Jones  et  al,  1981)  was  mixed  with 
55 three  drops  of  1%  BCB  in  75  x  10  mm  test  tube.  The 
tubes  were  then  incubated  at  37°C  for  10,  20,  30  and 
60  minutes,  2,  3,  4  and  5  hours  and  then  dry  blood 
smears  were  prepared.  Because  of  the  high  incidence 
of  false  positive  results  in  control  samples  beyond 
one  hour  at  37°C,  patient  samples  were  studied  only 
to  one  hour  i.e.  10,  20,  30  and  60  minutes. 
6.2.3  counting  of  inclusion  bodies 
§mears  were  examined  using  an  oil  immersion  objective 
(magnification  x  1000).  To  ensure  that  sufficient 
red  cells  were  assessed,  300  fields  (approximately 
30,000  red  cells)  were  examined  using  the  technique 
illustrated  in  Figure  13.  If  only  one  cell  was  found, 
the  test  was  considered. as  positive  (Walford  and 
Deacon,  1976). 
7.  GLOBIN  CHAIN  SYNTHESIS  STUDIES 
7.1  Principle 
The  in  vitro  measurement  of  globin  chain 
synthesis  can  be  a  useful  method  of  characterising 
the  a-thalassaemias,  since  the  disease  arises  from 
an  inherited  defect  in  the  rate  of  synthesis  of  the 
alpha  globin  chain.  Reticulocyte-enriched  blood  IS 
incubated  In  a  buffer  containing  all  amino  acids 
necessary  to  sustain  globin  synthesis  and  a  radio-
active  tracer  amino  acid,  usually  3H-leucine. 
Leucine  is  chosen  because  there  are  equal  numbers 
of  leucine  residues  in  both  the  a  and  B chains  and. 
therefore, there  is  no  need  for  correction  of  radio-
activity.  The  entrance  of  leucine  into  the  red 
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Fig.  13  Schematic  drawing  illustrating 
method  of  counting  the  inclusion  bodies. cells  lS  rapid  and  its  passage  through  the  membrane 
is  not  the  rate-limiting  step  (Schwartz ,1974).  The 
cells  are  then  washed,  haemolysed  and  the  globin 
extracted  with  acid-acetone.  The  a  and  non-a  chains 
are  dissociated  and  separated  by  ion  exchange 
chromatography  on  carboxy  methyl  cellulose  (eM 
cellulose)  in  8M  urea.  The  chains  are  eluted 
separately  from  the  column  by  a  linear  gradient  of 
sodium  ions  at  acidic  pH  e.g.  the  more  positively 
charged  a  chains  are  eluted  at  a  higher  Na+ 
concentration.  Addition  of  mercaptoethanol  to  the 
buffer  keeps  the  sulphydryl  groups  of  the  globin 
chains  in  the  reduced  state  and  prevents  aggregation 
of  the  a  and  S  chains.  The  total  number  of  counts 
incorporated  into  each  peak  are  calculated  and  the 
a/S  ratio  lS  expressed  as  total  counts  a  peak 
total  counts  Speak 
The  a/S  ratio  approximates  at  1.0  in  normal 
individuals  whereas  it  is  increased  in  S-thalassaemia 
and  decreased  in  a-thalassaemia  in  proportion  to  the 
severity  of  the  defect. 
7.2  Method 
7 . 2 . 1  Globin  preparation 
7.2.1.1  Preparation  of  a  reticulocyte  rich  suspension: 
20  ml  of  heparinised  blood  was  centrifuged  at 
1,100  g  for  5  minutes  and  the  packed  cells  washed 
three tirres·. wit h  nor m  a I  s a lin  e .  The  washed  red  cells 
57 were  subjected  to  ultracentrifugation  (Beckman 
Model  L5-65)  at  9200  g  for  10  minutes  at  4°C. 
7.2.1.2  Globin,  incubation 
1  ml  from  the  upper  layer  of  the  packed  cells 
was  added  to  3  ml  of  leucine-free  amino  acid 
mixture,  prepared  as  described  by  Lingrel  and 
Borsook  (1963)  and  stored  ln  batches  at  -20°C  until 
used.  Glutamine  (0.15  ml  of  a  0.1461  g/100  ml 
saline  solution)  was  added  to  the  incubation  medium 
to  replace  that  of  the  amino  acid  mixture  which 
denatures  during  storage.  Ferrous  ammonium  sulphate 
(0.18  ml  of  0.1  g/100  ml  H20  solution)  was  added  as 
a  soluble  source  of  lron. 
The  incubation  mixture  was  completed  by  the 
addition  of  100  ~l  H3  leucine  (radioactive 
con c e n t rat ion  1. 0  m ci / m  I ; 
45  Cl!  m  mol,  [ Am e r s ham] ) . 
specific  activity 
This  mixture  was  then  incubated  at  37°C  for.one 
hour  and  washed  three  times  with  10  ml  cold  phosphate 
buffered  saline  (Sigma  Chemicals)  to  remove  any  free 
isotope.  Finally  the  red  cells  were  lysed  in  5  ml 
distilled  water. 
7.2.1.3  Globin  separation 
To  remove  the  haem  group,  /  the  haemolysate  was 
added  dropwise  to  100  ml  of  a  1.5%  (W/V)  solution 
of  concentrated  hydrochloric  acid(HCI)'  in  acetone 
with  continuous  stirring.  The  precipitated  globin 
was  centrifuged  and  the  brown  supernatant  containing 
58 the  haem  discarded.  The  globin  was  washed  three 
times  in  acetone  (BOH,  ANALAR)  to  remove  any  trace 
of  acid,  dried  in  a  nitrogen  stream  and  stored  at 
_20DC  until  used. 
7.2.2  Globin  chain  separation 
The  globin  chains  derived  from  the  haemoglobin 
were  separated  by  the  method  of  Clegg  et  al  (1966). 
7.2.2".1  Reagents/Equipment 
Solutions 
The  following  solutions  were  freshly  prepared 
before  use:-
8M  Urea 
This  was  prepared  by  dissolving  720  gm  Urea 
(BOH  Analar  grade)  in  900  ml  of  distilled  water. 
The  solution  was  filtered  to  remove  any  impurities 
and  made  up  to  1.5  1  with  distilled  water. 
Buffers 
Buffer  8M  urea 
Inital(0.005M)  1200  ml 
Final  (.03M)  300  ml 
N~2HP04·2H20 
Sorensen'salt 
1.068  gm 
1.602  gm 
2-mercapto-
ethanol 
4  ml 
1  ml 
The  solutions  were  adjusted  to  pH  6.7  with 
concentrated  phosphoric  acid  (H 3P04 )  [BOH). 
Carboxymethyl  Cellulose  (CM) 
5  gm  of  fines  reduced  CM  23  cellulose  (Whatman) 
was  made  into  a  slurry  with  100  ml  initial  buffer 
and  left  to  settle  for  one  hour. 
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Chromatography  column 
A  column  of  dimension  1.5  cm  x  30  cm 
(Pharmacia)  was  used. 
Dialysis  membrane 
Dialysis  membrane  of  SIze  8/32  (Scientific 
Instrument  Limited). 
7.2.2.2  Method 
100  mg  of  H3-labelled  globin  were  dissolved  In 
5  ml  initial  buffer,  and  dialysed  against  100  ml  of 
initial  buffer  for  2  hours  to  reduce  the  sulphydryl 
groups  of  globin.  Meanwhile  the  cellulose  slurry 
was  poured  into  the  column  and  packed  very  carefully 
at  atmospheric  pressure  to  form  a  bed  20  cm  in 
height.  The  column  was  then  equilibrated  with  initial 
buffer  at  a  flow  rate  of  1  ml/min.  for  30  minutes, 
the  rate  of  flow  being  adjusted  by  a  peristaltic  pump 
(Pharmacia).  The  sample  was  then  loaded  onto  the 
column  under  gravity  using  a  Pasteur  Pipette  and  the 
residual  proteins  were  washed  on  with  a  further  2  ml 
of  the  initial  buffer.  The  globin  remains  firmly 
bound  to  the  CM  cellulose  at  the  top  of  the  column. 
The  column  was  washed  for  30-40  minutes  using  the 
initial  buffer  to  elute  unbound  protein.  The  globin 
was  then  eluted  from  the  column  by  a  linearly 
increasing  Na+  ion  concentration  generated  in  8  two 
chamber  mixer  containing  equal  volumes  (300  ml)  of 
initial  and  final  buffers.  At  acidic  p~ a  and  non 
a-chains  elute  separately  from  the  column  at 
60 characteristic  Na+  lon  concentrations.  10  ml 
fractions  were  collected  (ISCO  Model  328  fraction 
collector)  and  the  optical  density  of  the  eluate 
was  monitored  continuously  at  280  nm  (ISCO  Model 
UA-5  absorbance/fluorescence  monitor). 
7.2.3  Counting 
A  1  ml  aliquot  from  each  fraction  was  pipet ted 
into  a  polyethylene  vial  (Packard)  containing  10  ml 
of  a  scintillation  fluid  (Scintillator  299™ 
[Packard])  and  mixed  thoroughly.  The  radioactivity 
of  each  aliquot  was  counted  for  one  minute  in  a 
liquid  scintillation  counter  (Packard  Model  3300). 
The  radioactivity  incorporated  in  a  and  6  chains 
was  counted  and  the  a/6  ratio  expressed  as  follows:-
a/6  -
Total  counts  under  a  peak 
Total  counts  under  6  peak 
61 RESULTS 
62 1 .  RED  CELL  MEASUREMENTS 
Table  II  contrasts  red  cell  measurements  in  normal 
controls  and  in  subjects  with  suspected  a  thalassaemia 
trait.  Males  and  females  were  analysed  separately. 
Significant  differences  in  data  sets  between  the  groups 
are  shown  using  the  'pi  value  (Table  III).  It  is  clear 
that  the  mean  values  of  MCV,  MCH  and  MCHC  of  patients  of 
both  sexes  were  significantly  lower  than  controls 
(p~0.001).  While  the  RBC  was  increased  in  both  sexes, 
the  increase  only  attains  significance  in  females 
(p<'0.001).  The  HGB  was  slightly  reduced  in  patients  of 
both  sexes  when  compared  wi th  controls  (p ~ .01 ).  Male 
and  female  patients  did  not  differ  with  the  exception  of 
the  RBC  (p..:::..  0.001). 
63 MALES  FEMALES 
Red  cell  Suspected a  Suspected a  rreasurerents  Controls  thalassaemia  Controls  thalassaemia 
trait  trait 
n  = 10  n  = 14  n  = 10  n  = 18 
RBC  (1012/1)  5.03±0.29  7.3±2.4  4.38±0.2  5.11±0.3 
HGB  (g/dl)  15-. 4±0. 9 .  13.4±1.7  13.3±0.7  12L2±1.0 
HCT  (1/1)  0.44±0.02  0.40±0.02  0.38±0.02  0.36±0.02 
MCV  (fl)  89.5±4.2  68.0±4.9  89.0±4.0  72.0±5.6 
MCH  (pg)  30.7±1.5  22.3±2.1  30.8±1.8  23.8±2.0 
MCHC  (g/dl)  33.9±0.9  32.5±0.7  34.4±0.6  32.6±1.0 
ROW  (?~)  13.1±0.8  14.3±0.9  13.2±0.8  14.1±1.0 
TABLE  II:  Red  cell  measur~ments in controls  and  in  suspected 
a-thalassaemia trait subjects  (32)  expressed  as  mean  ±  standard 
deviation. 
64 Control  Control  Control  Patients 
Red  cell  males  vs  males  vs  females  (male) 
parameters  control  patients  v-- .:J  vs . 
females  (male)  patients  patients 
(female)  (female) 
RBC  (1012/1)  p.::  .001**  p<.01*  pc001**  p~.001** 
HGB  (g/dl)  p.( .001**  p<.01*  p.(.01  *  p<.03 
HCT  (1/1)  pL... 001 **  p~.01*  p<.01  *  pc02 
MCV  (fl)  p z  .7  p<.001**  p<.001**  p<.04 
MCH  (pg)  pL...8  p<:.001**  pc  001 **  p<.04 
MCHC  (g/dl)  p.( . 1  pc001**  p<.001**  p<.7 
ROW  O~)  p « .  7  p<.01  *  pc02  p4.5 
TABLE  III:  Statistical analysis  of  red  cell measurements  for 
normal  controls  and  suspected a  thalassaemia trait subjects 
p<. .001**  highly  significant 
pL..  .01  *  significant 
65 2.  HAEMOGLOBINOPATHY  INVESTIGATIONS 
All  patients  had  normal  Hb  electrophoresis,  normal 
levels  of  HbF  and  HbA 2  (Table  IV). 
The  normal  ranges  in  the  laboratory  for  HbF  and  HbA 2 
are <  1%  and  ~  3.2%  respectively. 
66 Hb 
electrophoresis 
controls  normal 
patients  normal 
HbF 
01 
10 
H  b F ~ 1  ?~ 
H  b F ~  1?~ 
0/ 
10 
(mean±S.D. ) 
2.5±0.3 
2.3±0.4 
TABLE  IV:  Hb  electrophoresis,  HbF  percentage  and  HbA 2 
percentage  in  the  controls  (20)  and  suspected 
a  thalassaemia  trait  patients  (32) 
67 3.  SERUM  FERRITIN  LEVEL 
Six  out  of  the  thirty-two  suspected  a  thalassaemia 
trait  subjects  were  found  to  have  iron  deficiency 
(ferritin ~ 12  ng/ml),  the  remainder  having  normal  levels 
(normal  range  12  - 400  ng/ml).  Results  are  shown  In 
Table  V.  As  shown  in  Table  VI  males,  both  controls  and 
patients  whose  serum  ferritin  levels  fall  within  the 
normal  range,  had  significantly  more  ferritin  than  was 
detected  in  females  (p<.01).  No  significant  difference 
was  noted  between  controls  and  patients  of  the  same  sex 
(Table  VI). 
68 Sex  control 
Males  n  10 
133±105 
Females  n  1 0 
43±  34 
patients  with 
normal  ferritin 
n  =  1 2 
186±125 
n  14 
66±  42 
patients 
with  iron 
deficiency 
n  2 
4±.7 
n  4 
7±3 
TABLE  V:  Serum  ferritin  levels  (ng/ml)  In  normal  controls 
and  suspected  a  thalassaemia  trait  subjects  expressed  as 
mean  ±  standard  deviation 
69 control  males  control  males  control  females  patients  (male) 
vs  vs  vs  vs 
control  females  patients(male)  patients(female)  patients(female) 
p ~ .01 *  P « .  3  p < .1  p ~ .01 * 
TABLE  VI:  Statistical analysis  of serum  ferritin  levels  (ng/ml) 
in controls  and  suspected a  thalassaemia trait subjects  with 
normal  ferritin  levels. 
patient:  suspected a  thalassaemia trait subjects  with  normal' ferritin 
p <  .01*  significant 
70 4.  DEMONSTRATION  OF  HbH  INCLUSIONS 
Routine  Method 
As  shown  In  Table  VII  approximately  half  the 
patients  gave  positive  results  with  the  Hbrl  inclusion 
test  indicating  the  presence  of  a  thalassaemia  trait. 
However,  globin  chain  synthesis  studies  were  performed 
on  all  patients  irrespective  of  whether  HbH  inclusions 
were  detected  or  not. 
71 Number  of patients 
patients with 
normal  ferritin 
patients with 
iron  deficiency 
TA8LE  VII:  ROUTINE  METHOD 
26 
6 
Number  of patients 
with  positive results 
14 
2* 
HbH  inclusion test  in  suspected  a  thalassaemia trait at  25°C  for 
24  hours  using  1%  8C8. 
*  These  2  patients  were  diagnosed  as  having  a  thalassaemia trait/ 
iron deficiency  by  globin  chain  synthesis studies. 
72 5.  GLOBIN  CHAIN  SYNTHESIS  STUDIES 
The  results  are  expressed  as  a/S-radioactivity 
ratios.  Precisi6n  studies  were  performed  by  measuring 
five  replicated  analysis  on  one  control  subject  and  on 
one  patient.  The  results  of  these  and  their  respective 
coefficients  of  variation  are  shown  in  Table  VIII. 
Patients  and  control  results 
The  results  of  globin  chain  synthesis  studies  are 
shown  in  Table  IX  and  are  categorised  as  follows 
(Figure  14):-
A  The  control  group  was  found  to  have  a  mean  a/S 
ratio  of  1.16±0.10. 
B  The  four  suspected  a  thalassaemia  trait  patients 
with  lron  deficiency  and  negative  HbH  inclusion  tests, 
had  normal  a/S  ratios  (1.15±0.14)  and  were,  therefore, 
diagnosed  as  lron  deficient.  The  other  two  patients 
suspected  to  have  iron  deficiency  on  the  basis  of  low 
serum  ferritin  levels  and  who  showed  positive  HbH  inclusion 
tests  had  low  a/S  globin  chain  ratios  (0.63  and  0.71) 
indicating  that  they  had  combined  a  thalassaemia  trait/ 
iron  deficiency,  and  are,  therefore,  included  with 
a  thalassaemia  trait  in  category  D. 
C  This  patient  had  a  normal  serum  ferritin  and  a 
negative  HbH  inclusion  test  but  was  found  to  have  a  high 
a/S  ratio  (2.14)  and  was,  therefore,  diagnosed  as 
S  thalassaemia  trait  with  a  normal  HbA 2  level. 
D  The  remaining  patients  with  normal  ferritin  levels 
73 who  either  gave  positive  or  negative  results  in  the  HbH 
inclusion  test  were  found  to  have  reduced  alB  ratios 
(0.85±0.12)  when  compared  with  controls  (p< .001). 
patients  were  diagnosed  as  a  thalassaemia  trait. 
74 
These Replicate  of a/S  ratios  Mean±SD 
Control  1.00;  1.01;  0.99;  1.00;  1.01  1.0±0.01 
Patient  0.70;  0.69;  0.70;  0.69;  0.71  0.70±0.01 
Co-efficient 
of variation 
1
0/ 
,0 
1 •  4?~ 
TABLE  VIII:  Precision  of a/S  globin  chain  ratio method 
75 controls 
1 .00  1 . 19 
1 .01  1 . 19 
1 .02  1.26 
1.04  1 .26 
1 .10  1.30 
1 .10  1 .36 
1 .10  1 .36 
1 .10 
1 . 14 
1. 15 
1 .17 
1 . 17 
1 . 18 
patients 
with  iron 
deficiency 
1 .04 
1.05 
1 . 16 
1.36 
0.63 
0.71 
patients 
with  normal 
serum  ferritin 
0.63  0.91 
0.66  0.91 
0.70  0.93 
0.72  0.94 
0.73  0.96 
0.77  0.97 
0.77  0.97 
0.84  0.98 
0.85  0.98 
0.86  0.99 
0.87  0.99 
0.88  1 .00 
0.90  2. 14 
TABLE  IX:  a/S  ratios  in controls  and  suspected 
a  thalassaemia trait subjects 
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Fig.  14  Globin  chain  synthesis  in  controls  and 
suspected  ex.  thalassaemia  trait. 
A = controls  B = iron  deficiency 
C =  f3  thalassaemia  trait  D =  ex. thalassaemia  trait 
--mean  ----- standard  deviation  • 6.  ROW  IN  a  THALASSAEMIA  TRAIT  AND  IRON  DEFICIE~CY 
The  normal  range  of  ROW  is  from  11.8  - 14.8%.  All 
controls  lay  within  this  range  (Figure  15).  Of  the 
27  patients  with  a  thalassaemia  trait,  6  had  marginally 
elevated  ROW  levels  in  the  range  14.8  - 15.0%.  In  the 
a  thalassaemia  group  were  two  patients  with  iron 
deficiency  in  addition  (ROW  of  13.6  and  14.5).  Four  of 
the  original  patient  group  did  not  have  a  thalassaemia 
but  simply  iron  deficiency.  Of  these,  one  patient 
possessed  an  ROW  in  the  normal  ~ange,  the  other  three 
having  elevated  levels.  See  Appendice  I. 
7.  DEMONSTRATION  OF  HbH  INCLUSIONS  IN  a  THALASSAEMIA  TRAIT 
7.1  Routine  Method 
Results  of  HbH  inclusion~  testing  in  the  group  of 
a  thalassaemia  trait  patients  performed  on  whole  blood 
incubated  for  24  hours  at  25°C  are  shown  in  Table  X.  The 
mean  value  for  HbH  inclusions  in  this  group  is  2.6  per 
30,000  RBC  with  a  range  of ° - 8  per  30,000  RBC.  However, 
it  is  important  to  note  that  of  the  27  patients  with 
a  thalassaemia  trait,  11  patients  did  not  show  HbH 
inclusions. 
7.2  Experimental  Method 
7.2.1  Whole  blood  method  varying  incubation  time  and 
temperature  with  and  without  potassium  iodide  (KI) 
stimulation 
Table  XI  shows  results  obtained  at  25°C 
incubation.  Table  XII  shows  results  obtained  at  37°C. 
77 1  1 
10 
Controls 
(n = 20) 
ex. tha 1  assaem i a 
trait 
(n = 27) 
Iron 
deficiency 
(n = 4) 
Fig.  15  Comparison  of  RDW  (%)  in  controls,  ex.  thalassaemia 
trait and  iron  deficiency. 
-- mean  ---- standard  deviation HbH  inclusion  bodies  start  to  appear  after  two 
hours incubation  at  25°C.  No  HbH  inclusion  bodies 
were  found  in  control  subjects.  The  addition  of  KI 
had  no  effect.  However,  at  37°C  the  HbH  inclusions 
started  to  appear  in  patients  after  10  minutes 
incubation  and  increased  progressively.  At  370C 
following  2  hours  incubation  controls  started  to  show 
HbH  inclusion  positivity  but  not  of  the  magnitude 
observed  in  patients.  Again  the  addition of  KI  does 
not  produce  any  particular  advantage. 
From  these  experiments:-
(a)  The  number  of  HbH  inclusions  apparently 
reaches  a  maximum  at  5  hours  (Figure  16),  at  250C. 
(b)  Incubation  at  37°C  for  1  hour  results  in 
the  formation  of  similar  numbers  of  HbH 
inclusions  (Figure  16). 
(c)  False  positive  results  emerge  In  the 
control  group  after  2  hours  incubation  at  37°C. 
7.2.2  Centrifuged  blood  method  varying  incubation 
time  (temperature  37°C  only;no  KI  addition) 
Using  this  method  controls  showed  false 
positivity  commencing  after  2  hours  incubation  and 
increasing  progressively.  Patients,  on  the  other 
hand,  showed  a  major  progressive  increase  in  HbH 
inclusions  from  10  minutes  incubation  to  1  hour 
incubation  (Table  XIII). 
78 Case 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1  1 
12 
13 
14 
15 
16 
Routine 
examination 
1 
1 
8 
8 
3-
0 
1 
0 
0 
5 
0 
4 
0 
5 
1 
6 
Case 
number 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
Routine 
examination 
5 
0 
0 
8 
0 
0 
0 
4 
1 
0 
5 
TABLE  X:  The  number  of  HbH  inclusion  bodies  counted  in  30,000 
RBC  in a  thalassaemia trait patients  by  routine  method. 
79 Incubation 
time 
10  minutes 
20  minutes 
30  minutes 
60  minutes 
2  hours 
3  hours 
4  hours 
5  hours 
controls 
n=20 
1%  BCB  1?~  BCB-K I 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
a  thalassaemia trait. 
n=27 
1?~  BCB  1?~  BCB-KI 
nil  nil 
nil  nil 
nil  nil 
nil  nil 
*  0.4  *  0.3 
;.  0-3  ;.  0-2 
*  1. 1  *  1. 1 
;.  0-6  ;.  0-5 
*  1.8  *  1.6 
;.  0-8  ;.  0-8 
*  2.7  *  2.8 
;.  0-8  ;.  0-8 
TABLE  XI:  Whole  blood  method  varYlng  incubation  time  at 
250C  with  and  without  potassium  iodide 
KI:  potassium  iodide 
*  mean 
;.  observed  range 
80 controls  a  thalassaemia trait 
n=20  n=27 
Incubation 
time  1%  BCB  1%  BCB-KI  1  ~~  BCB  1%  BCB-KI 
10  minutes  nil  nil  *  0.1  nil 
j.  0-1 
20  minutes  nil  nil  *  1. 1  ±  *  1. 1 
j.  0-4  j.  0-3 
30  minutes  nil  nil  *  1. 9  *  1. 7 
j.  0-6  j.  0-5 
60  minutes  nil  nil  *  2.7  *  2.8 
j.  0-10  j.  0-10 
2  hours  *  0.2  *  0.3  *  3.8  *  3.7 
j.  0-2  j.  0-1  j.  0-12  j.  0-11 
3  hours  *  0.8  *  0.8  *  4.0  *  4. 1 
j.  0-3  j.  0-2  j.  0-12  j.  1-10 
4  hours  *  1. 1  *  1. 1  *  4.7  *  4.6 
j.  0-3  j.  0-2  j.  1-13  j.  2-12 
5  hours  *  1.5  *  1.6  *  5.0  *  5.3 
j.  1-4  j.  1-3  j.  2-13  j.  2-14 
TABLE  XII:  Whole  blood  method  varying  incubation  time  at 
370C  with  and  without  potassium  iodide. 
*  mean  j.  observed  range 
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Fig.  16  Mean  number  of  Hb  H inclusions  in 
~  thalassaemia  trait  (27)  using  whole  blood  for 
1 hour  at  370CJ  5 and  24  hours  at 25°C. Incubation 
time 
10  minutes 
20  minutes 
30  minutes 
60  minutes 
Controls 
n=20 
nil 
nil 
nil 
nil 
2  hours  *0.2 
3  hours 
4  hours 
5  hours 
f.  0-1 
*  0.3 
f.  0-2 
*  0.6 
f.  0-2 
*  1. 2 
f.  1-3 
a  thalassaemia trait 
n=14 
*  0.6 
f.  0-4 
*  4.8 
f.  0-20 
*  7.0 
f.  0-35 
*  15.0 
f.  0-41 
TABLE  XIII:  Centrifuged  blood  method  varyIng  incubation  time 
at  37°C 
*  mean  f.  observed  range 8.  CLASSIFICATION  OF  a  THALASSAEMIA  TRAIT 
Based  on  blood  count  measurements  globin  chain 
synthesis  studies  and  the  demonstration  of  HbH  inclusion 
bodies  in  routine  and  experimental  methods,  the  27 
patients  with  a  thalassaemia  trait  could  be  further 
classified  into  two  types:-
8.1  a  Thalassaemia  2  "mild  form" 
There  were  9  patients  in  this  group  who  were 
characterised  by  :-
(a)  MCV  values  between  75-79  fl  and  MCH  values  between 
25-27  pg  with  mean  values  significantly  less  than 
controls  (p <.001)  [Figures  17  and  18]. 
(b)  Negative  results  with  HbH  inclusion  test. 
(c)  Mean  a/S  globin  chain  ratio  0.96±0.04  [Figure  19] 
which  is  signi ficantly  less  than  control  (p <.  .001). 
8.2  a  Thalassaemia  1  or  homozygous  a  thalassaemia  2 
"severe  form" 
There  were  18  patients  included  in  this  group.  These 
patients  were  characterised  by:-
(a)  MCV  values  between  60-72  fl,  MCH  values  between 
19-24  pg  with  mean  values  significantly  less  than 
the  mild  state  (p< .001)  [Figures  17,18]. 
(b)  Positive  results  with  HbH  inclusion  test. 
(c)  Mean  a/S  globin  chain  ratio  of  0.79±.11  which  1S 
also  significantly  less  than  the  mild  group  (p <.  .001) 
[Figure  19]. 
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-- mean  ----- standard  deviation 9.  a  THALASSAEMIA  TRAIT  IN  DIFFERE~T  RACIAL  GROUPS 
The  27  a  thalassaemia  trait  patients  were  further 
divided  by  race  into:-
14  Indians  (8  mild  form  and  6  severe  form) 
12  Chinese  (1  mild  form  and  11  severe  form) 
1  Negro  (severe  form) 
None  of  the  patients  were  related  to  each  other. 
9.1  Red  Cell  Measurements 
A  comparison  of  red  cell  measurements  in  Indian 
and  Chinese  patients  with  the  severe  form  of  a  thalassaemia 
trait  shows  no  significant  difference  between  the  two 
ethnic  groups  (Table  XIV).  Comparison  of  mild  and  severe 
forms  in  Indians  demonstrated  highly  significant 
differences  in  the  MCV  and  MCH  (p.t...001)  [Table  XVJ. 
There  were  insufficient  Chinese  mild  form  patients  to 
permit  any  comparison  with  the  mild  Indian  patients. 
9.2  Serum  Ferritin  Level 
Serum  ferritin  levels  in  Chinese  males  are 
significantly  greater  than  those  observed  in  control 
males  (p <.  .01),  Chinese  females  (p < .001)  and  Indian 
males  (p<  .001)[Tables  XVI,  XVIIJ.  There  IS  no 
significant  difference  between  males  and  females  In 
the  Indian  group  (p < .3). 
9.3  Demonstration  of  HbH  Inclusion  Bodies 
As  mentioned  before  inclusion  bodies  are  observed 
only  In  the  severe  form  of  the  disorders.  Therefore 
the  following  experimental  studies  to  assess  racial 
84 differencesin  occurrence  of  HbH  inclusions  were 
restricted  to  those  patients  with  the  severe  form 
(a  thalassaemia  1  or  homozygous  a  thalassaemia  2). 
The  mean  number  of  HbH  inclusions  observed  in 
Indian,  Chinese  and  Negro  patients  with  the  whole 
blood  method  at  25°C  and  37°C  are  shown  in  Table  XVIII. 
At  37°C  tests  were  only  performed  with  incubation 
periods  ranging  from  10-60  minutes,  because  of  the 
occurrence  of  false  positive  results  beyond  that  time 
in  the  control  group.  The  number  of  inclusions  in  the 
Chinese  group  is  six  and  eight  times  greater  than  Negro 
and  Indian  values  respectively  following  incubation  for 
5  hours  at  25°C.  The  number  of  inclusions  present 
following  incubation  for  1  hour  at  37°C  IS  SIX  and  nIne 
times  greater  in  the  Chinese  group  than  In  the  Negro  and 
Indian  values  respectively  [Figure  20J. 
Although  centrifugation  increases  the  number  of 
inclusions  in  the  Chinese  group  approximately  five  times 
over  that  obtained  in  the  whole  blood  method,  the  increase 
in  the  Indian  group  is  only  by  a  factor  of  three  (Table 
XIX)[Figures  20,21J. 
9.4  Globin  Chain  Synthesis  Studies 
Results  of  globin  chain  synthesis  studies  are 
illustrated  in  Table  XX.  The  alB  ratios  in  the  different 
geographical  groups  are  illustrated  in  Figure  22.  The 
alB  ratios  in  Indians  with  the  severe  form  of  a 
thalassaemia  trait  are  significantly  less  than  in  the 
Chinese  group  (p < .001). 
85 Globin  chain  synthesis  correlates  positively  with 
MeV  in  both  forms  of  the  trait  in  the  Indian  group 
[Figure  23J. 
10.  TWO  FORMS  OF  a  THALASSAEMIA  TRAIT  IN  INDIANS 
Table  XXI  summarised  variation  in  the  haematological 
studies  between  mild  and  severe  forms  in  Indians. 
indicate  clear  separation  of  the  two  groups. 
86 
These Red  cell 
Measurement 
RBC  X 1012/1 
HGB  g/dl 
HCT  1/1 
MCV  fl 
MCH  pg 
MCHC  g/dl 
ROW 
01 
10 
Severe  form 
In  Indians 
n=6 
5.43±0.66 
11.9±1.5 
0.36±0.04 
67.9±0.9 
21.9±0.5 
32.2±0.7 
13.9±0.9 
Severe  form  Indians 
In  Chinese  vs 
n=11  Chinese 
6.16±0.73  p.( .06 
12.8±1.6  p< .2 
0.39±0.05  p <  .2 
65.2±3.1  p (  .05 
21.1±1.0  p ~ .08 
32.4±0.6  p<. .5 
14.4±0.7  p < .22 
TABLE  XIV:  Comparison  of  red  cell measurements  between 
Indian  and  Chinese  severe  form  of a  thalassaemia trait. 
Results  expressed  in  mean  ± standard  deviation. 
87 Red  cell 
measurements 
RBC  X 1012/1 
HGB  g/dl 
HCT  1/1 
MCV  fl 
MCH  pg 
MCHC  g/dl 
RDW 
01 
10 
mild  form 
n=8 
5.25±0.60 
13.5±1.4 
0.40±0.04 
77.9±1.8 
25.9±0.6 
32.8±1.5 
13.6±0.5 
severe  form  mild  form 
n='6  vs 
severe  form 
5.43±0.66  p  .L..  .6 
11.9±1.5  pL....06 
0.36±0.04  p  .(  .08 
67.9±0.9  p  .(  .001** 
21.9±0.5  p  ~ .001** 
32.2±0.7  p  ~ .38 
13.9±0.9  pL...43 
TABLE  XV:  Comparison  of red  cell measurements  between  the 
mild  and  the  severe  form  of a  thalassaemia trait in  Indians. 
Results  expressed  in  mean  ± standard  deviation. 
P<' .001**  highly  significant 
88 Sex 
Males 
Females 
Controls 
n=10 
133±105 
n=10 
43±34 
Indians 
n=-4 
55±36 
n= 8 
70±52 
Chinese 
n=7 
272±90 
n=5 
46±30 
TABLE  XVI:  Serum  ferritin  level  (ng/ml)  In  controls, 
Indian  and  Chinese  a  thalassaemia trait.  Results 
expressed  in  mean  ±  standard  deviation. 
89 Cmtrol rrnles  Irdian rrnles  Dlirese rmles  Irdian rmles  Irdian f males 
vs  vs  vs  vs  vs 
Centrol  fEflBles  Irdian fBTBles  Dlirese fBTBles  Dlirese rmles  Dtirese fBTBles 
p< .01*  p <..3  p< .001**  p< .001**  p< .3 
TABLES  XVI]  :  Statistical analysis of serum  ferritin levels (ng/ml)  in controls, 
Indian ard Dlirese a  thalassaenia trait 
p <  .01 *  sigli  f icant 
p <  .001 **  higu  Y sigli  f icant 
90 Incubation  temperature 
Incubation  25°C  37°C 
time 
Negro  Indians  Chinese  Negro  Indians  Chinese 
(n=1 )  (n=6)  (n-11 )  (n=1 )  (n=6)  (n= 11 ) 
10  minutes  nil  nil  nil  nil  nil  *  0.1 
f.  0-1 
20  minutes  nil  nil  nil  nil  nil  *  2.7 
!  1-4  r 
30  minutes  nil  nil  nil  nil  nil  *  4.6 
f.  2-6 
60  minutes  nil  nil  nil  1  *  0.7  *  6.2 
f.  0-1  f.  3-10 
2  hours  nil  nil  *  1.0 
f.  0-3 
3  hours  nil  *  0.16  *  2.5 
f.  0-1  f.  1-6 
4  hours  nil  *  0.3  *  4.2 
f.  0-1  f.  2-8 
5  hours  1  .  *  0.7  *  5.8 
f.  0-1  f.  3-9 
24  hours  1  *  0.7  *  5.5 
f.  0-1  f.  3-8 
TABLE  XVIII:  Comparison  of  number  of  HbH  inclusions  (per 
30,000  RBC)  in  Indian,  Chinese  and  Negro  a  thalassaemia 
trait patients using  1%  BCB  at  25°C  and  37°C  with  whole  blood. 
*  mean 
f.  range 
91 Incubation 
time 
(minutes) 
10 
20 
30 
60 
Indians 
(n=4) 
nil 
nil 
*  0.75 
I- 0-1 
*  2.0 
Chinese 
(n=8) 
*  1.1 
I- 0-4 
*  9.7 
I- 1-30 
*  13.4 
I- 4-37 
*  29.7 
I- 18-41 
TABLE  XIX:  Comparison  of number  of  HbH  inclusions  per 
30,000  RBC  in  Indian  and  Chinese  a  thalassaemia trait 
patients  using  centrifuged  blood  with  1%  BCB  at  37°C 
up  to  hour. 
*  mean 
observed  range 
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Chinese 
--- Indians SEVERE  FORM 
Indians  Chinese 
(n=6)  (n=11) 
0.63  0.77 
0.63  0.77 
0.66  0.84 
0.70  0.86 
0.71  0.87 
0.73  0.88 
0.90 
0.91 
0.91 
0.94 
0.95 
Negro 
(n= 1 ) 
0.72 
MILD  FORM 
Indians  Chinese 
(n=8)  (n= 1 ) 
0.85  0.99 
0.93 
0.97 
0.97 
0.98 
0.98 
0.99 
1 .00 
TABLE  XX:  alB  globin  chain  ratios  in  Indian,  Chinese .and 
Negro  a  thalassaemia trait. 
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Fig.  23  Correlation'betweencxl;3  ratios  and  MCV  fl 
in  Indian  ~  thalassaemia  traits. mild  form 
(n=8) 
MCV  fl  j.  77.9±1.8 
MCH  pg  j.  2S.9±0.6 
HbH  inclusion  All  negative 
test 
ctiS  ratio  j.  0.96±.04 
severe  form  mild  form 
vs 
(n=6)  severe  form 
j.  67.9±0.9  p <.  .001** 
j.  21.9±0.S  p <.  .001 ** 
All  positive 
j.  0.67±0.04  p < .001 ** 
TABLE  XXI:  Comparison  of haematological  studies  between  the 
mild  and  the  severe  forms  of a  thalassaemia trait in  Indians. 
j.  mean  ±  standard  deviation 
pL... 001 **  highly  signi  ficant 
94 DISCUSSION 
95 DISCUSSION 
The  routine  laboratory  tests  used  to  diagnose  a 
thalassaemia  trait  include  (1)  measurement  of  red  cell 
indices  i.e.  MCV,  MCH  and  MCHC,  (2)  examination  of 
peripheral  blood  film  and  (3)  demonstration  of  HbH 
inclusions. 
Difficulties  can  arise  in  differential  diagnosis:-
a.  Discrimination  of  thalassaemia  trait  from  the  other 
causes  of  red  cell  microcytosis  e.g.  iron  deficiency. 
This  can  be  achieved  by  measuring  the  serum  ferritin 
level  (ferritin  levels  below  12  ng/ml  indicating  iron 
deficiency). 
b.  Differentiation  of  a  thalassaemia  trait  from  B 
thalassaemia  trait  by  measurement  of  the  HbA 2  level 
(HbA 2  levels  greater  th~n  3.3%  indicating  B 
thalassaemia  trait). 
1.  RED  CELL  VOLUME  DISTRIBUTION 
In  this  study  the  red  cell  distribution  width  (RDW) 
has  been  examined  to  assess  its ability  to  distinguish 
between  a  thalassaemia  trait  and  iron  deficiency.  The 
RDW  is  a  very  rapidly  performed  test  available  on  second 
generation  fully  automated  blood  cell  counters  such  as 
the  Coulter  Counter  Model  S  Plus  IV.  The  other  second 
generation  fully  automated  blood  cell  counters  such  as 
the  Technicon  H1,  the  Ortho  ELT8,and  the  Sysmex  E5000 
produce  similar  measurements  of  red  cell  anisocytosis  but 
use  different  methods  of  obtaining  the  red  cell  volume 
distribution  data  and  none  is strictly  comparable  with 
96 any  of  the  others. 
The  red  cell son  the  pe r i ph e r aJ b 1 0 0 d  s mea r  In  Iron 
deficiency  are  well  known  to  show  hypochromia  and 
microcytosis  (Price,  1933;  Oaland  et  aI,  1946)  and 
those  two  features  have  formed  the  corner  stone  ot 
the  morphological  diagnosis.  England  et  al  (1976)  In  a 
study  of  subjects  with  latent  iron  deficiency  showed 
that  red  cell  anisocytosis  WdS  an  early  and  sensitive 
measurement  of  this  disorder.  This  observation  received 
further  support  from  the  work  of  Bessman  and  Feinstein 
(1979).  On  the  other  hand  Bessman  and  Feinstein  (1979) 
showed  that  patients  with  a  and  S  thalassaemia  trait 
possessed  red  cells  with  normal  or  only  slightly 
increased  variation  in  size. 
In  this  work  the  ROW  values  obtained  in  a  thalassaemia 
trai  t  and  in  iror. deficiency'  patients  agreed  wi th  those 
obtained  by  England  et  al  (1976)  and  Bessman  and  Feinstein 
(1979).  Nineteen  out  of  twenty  five  patients  with 
uncomplicated  a  thalassaemia  trait  had  no  anisocytosis 
(normal  ROW)  while  the  remainder  had  very  slight 
anisocytosis  (Figure  15).  Two  patients  with  combined  a 
thalassaemia  trait/iron  deficiency  showed  no  anisocytosis 
(normal  ROW).  However,  three  out  of  four  patients  with 
~ron  deficiency  showed  anisocytosis  (elevated  ROW). 
Overall,  therefore,  of  28  patients  who  either  had  very 
slight  or  no  anisocytosis  (ROW  L  15%)  but  with  significant 
reduction  In  MCV  and  MCH,  96%  were  classified  as  a 
thalassaemia  trait  and  4%  as  iron  deficiency. 
97 According  to  Bessman  and  Feinstein  (1979) ,ROW  values 
are  increased  In  iron  deficiency  and  normal  in  a 
thalassaemia  trait,  sinc~ red  cell  abnormalities  In 
thalassaemia  trait  are  not  progressive,  while  in  lron 
deficiency,  without  iron  replacement,  progressive  change 
in  red  cell  morphology  occurs.  In  evolving  iron 
deficiency  the  red  cells  most  recently  produced  are 
likely  to  be  the  smallest  cells  in  the  patient  population 
resulting  In  an  increased  percentage  of  microcytes  and 
an  increased  degree  of  anisocytosis  (England  et  aI, 
1976).  Such  does  not  exist  in  a  thalassaemia  trait. 
Although  the  morphological  abnormalities  described  in 
thalassaemia  trait  include  variation  in  red  blood  cell 
size  (Wintrobe,  1974)  this  anisocytosis  really  reflects 
the  existence  of  leptocytosis  or  poikilocytosis 
(Bessman  and  Feinstein,  1979). 
The  results  obtained  in  the  present  study  indicate 
that  the  ROW  may  be  used  as  a  rapid  and  reliable  test 
to  distinguish  between  iron  deficiency  and  a  thalassaemia 
trait.  Patients  with  an  MCV  L  79  fl,  and  MCH
L  27  pg  and 
a  normal  HbA
2 
level  are  most  likely  to  have  a  thalassaemia 
trait  if  in  additi~n.  they  have  an  ROW  value ~ 15%  and 
iron  deficiency  if the  ROW  value  is  greater. 
2.  HbA 2  LEVEL 
The  level  of  HbA  can  be  used  to  differentiate  between 
2 
a  thalassaemia  trait  and  S  thalassaemia  trait  on  most 
occasion~ being  elevated  in  the  latter.  However, patients 
with  heterozygous  "silent"  S  thalassaemia  trait 
98 have  normal  HbA Z  levels  (Weatherall  and  Clegg.  1981). 
Of  the  twenty-eight  patients  studied,  one  patient  fell 
into  this  category.  The  diagnosis  of  S thalassaemia 
trait  being  confirmed  on  the  basis  of  the  a/S  globin 
chain  synthesis  ratio.  The  remaining  twenty-seven 
patients  had  normal  HbA Z  levels.~ 3.3%  and  were  diagnosed 
as  a  thalassaemia  trait. 
3.  SERUM  FERRITIN  LEVEL 
Patients  with  uncomplicated  a  thalassaemia  trait 
had  normal  serum  ferritin  levels.  This  finding  is 
consistent  with  reports  that  serum  ferritin  is  normal 
in  both  a  and  S  thalassaemia  trait  (Weatherall  and  Clegg, 
197Z;  Hussein  et  aI,  1976;  Loria  et  aI,  1978; 
Carrell  and  Lehmann,  1983).  On  the  other  hand,  two 
patients  with  the  severe  form  of  a  thalassaemia  trait 
were  found  to  have  low  serum  ferritin  levels  indicating 
combined  a  thalassaemia-trait/iron< eeficiency.  This  last 
finding  supports  the  observation  that  while  iron  status 
in  patients  wit0  thalassaemia  trait  is  normal,  these 
patients  can  become  iron  deficient  for  any  reason 
(Hussein  et  aI,  1976). 
4.  DEMONSTRATION  OF  HbH  INCLUSION  BODIES 
4.1  Whole  Blood  Method 
The  effect  of  temperature  and  incubation  time  on  the 
number  of  inclusion  bodies  (Gouttas  et  aI,  1955)  was 
examined  In  this  work.  From  the  results  obtained  [Table 
XII],  it  is  obvious  that  at  37°C  inclusion  bodies  start 
to  appear  in  a  relatively  short  time  (after  10  minutes). 
99 In  contrast,  at  25°C,  inclusion  bodies  only  start  to  _ 
appear  after  2  hours  incubation  [Table  XIJ.  The  number 
of  inclusion  bodies  increases  progressively  with 
increasing  incubation  time  reaching  a  peak  after  5  hours 
at  25°C.  However  at  37°C,  "false  positive"  results  were 
obtained  at  two  hours'  incubation  in  control  subjects. 
This  agreed  with  the  observation  of  Dacie  and  Lewis 
(1984).  Wickramasingh e  et al  (1981),  however,  reported 
that  normal  red  cells  showed  little or  no  ultrastructural 
change  at  2  hours  incubation. 
Other  previous  work  on  the  HbH  inclusion  test  did  not 
report  false  positives  as  only  patients  seemed  to  be  used 
with  no  control  groups  (Schwartz  and  Atwater,  1972; 
W  a 1 for dan  dOe  a con,  1 9 7 6 ;  Win i c hag  '0 0 net aI,  1 9 8 0 ) . 
In  the  whole  blood  method  used  in  this  study,  the 
number  of  inclusions  obtained  at  37°C  for  one  hours 
incubation  was  the  same  as  that  obtained  by  the  routine 
method  at  25°C  for  24  hours.  As  a  result  the  inclusion 
bod.y  preparations  could  be  examined  after  one  hour 
instead  of  24  hours  provided  an  incubation  temperature  of 
37°C  was  used  (Figure  16).  At  both  temperatures  (25°C 
and  37°C)  with  varying  incubation  times,  the  use  of 
potassium  iodide  (Pereira,  1984),  as  a  stimulant  to 
increase  the  number  of  HbH  inclusions  formed,  does  not 
show  an  advantage  [Tables  XI,  XIIJ. 
4.2  Centrifuged  Blood  Method 
As  reported  previously  (Jones  et  al,  1981; 
Maungsapaya  et  aI,  1985),  the  number  of  HbH  inclusion 
100 bodies  produced  uSlng  a  centrifugation  method  was 
greatly  enhanced  in  patients  with  a  thalassaemia  trait. 
Unlike  the  findings  of  some  other  workers,  (Walford 
and  Deacon,  1976;  Jones  et  aI,  1981),  centrifugation 
by  the  Wintrobe  technique  as  described  by  Raven  and 
Tooze  (1973),  proved  to  be  a  suitable  technique  to 
obtain  sufficient  reticulocyte-enrichment.  The 
percentage  of  reticulocytes  obtained  by  the  Wintrobe 
technique  in  this  study  (about  10%)  is  nearly  the  same 
as  that  obtained  by  the  microhaematocrit  technique  (13%) 
(Jones  et  aI,  1981).  An  increase  in  the  speed  of 
centrifugation  is  known  to  augment  the  percentage  of 
reticulocytes  obtained.  However  the  centrifugation 
speed  of  6,000  rpm  used  In  this  study  with  the  Wintrobe 
technique  is  actually  half  that  used  by  the  microhaemato-
crit  method  (12,000  rpm)  which  might  indicate  that,  with 
equivalent  speed,  a  higher  per~entage  of  reticulocytes 
could  be  obtained  by  the  Wintrobe  method.  With  the 
Wintrobe  technique,  it is  quite  easy  to  obtain  a  drop 
of  centrifuged  blood  from  the  tube  by  a  Pasteur  pipette; 
with  the  microhaematocrit  technique  it  is  very 
difficult  to  expel  the  centrifuged  blood  from  the  area 
below  and  above  the  plasma/cell  interface. 
Raven  and  Tooze  (1973)  using  centrifuged  blood, 
recommended  3  hours  incubation  at  37°C.  In  the 
present  study,  control  subjects  started  to  show  "false 
101 positive"  results  for  incubation of  more  than  one  hour. 
at  37°C.  It  can,  therefore,  be  concluded  that  at  370C 
incubation  time  must  not  exceed  one  hour. 
5.  GLOBIN  CHAIN  SYNTHESIS  STUDIES 
5.1  Normal  individuals 
The  normal  range  of  globin  chain  synthesis  ratios 
In  20  control  subjects  in  this  study  was  found  to  be 
1.06  - 1.26  in  agreement  with  that  obtained  by  Higgs 
et  al  (1979,  1980b).  In  early  studies  by  Kan  et  al 
(1968)  and  Schwartz  et  al  (1969),  the  normal  range 
in  10  control  subjects  was  0.95  - 1.10.  In  1975 
Pootrakul  et  al  demonstrated  a  range  of  1.0  - 1.2 
in  8  controls  while  Walford  and  Deacon  (1976)  observed 
a  range  of  0.9  - 1.26  in  20  controls.  This  shows  the 
variation  in  normal  range  from  one  study  to  another. 
5.2  a  Thalassaemia  Trait  Patients 
The  mean  a/S  ratio  in  the  severe  form  of  a 
thalassaemia  trait  in  this  study  (0.79±.10)  was  foupd 
to  be  comparable  to  that  observed  in  the  obligatory 
carriers  of  a  thalassaemia  1  trait  reported  by 
Kan  et  al  (1968),  Schwartz  et  al  (1969)  [0.77±.05] 
and  Pootrakul  et  al  (1975)  [0.78±0.03J.  While  in  the 
mild  form  of  a  thalassaemia  trait,  the  mean  a/S 
ratio  (0.96±0.04)  encountered  in  the  present  study. 
is  comparable  with  that  reported  for  obligatory  carriers 
102 of  a  thalassaemia  2  trait  (0.92±0.03)  (Pootrakul  et 
aI,  1 9 7 5  c),) , 
Although  there  are  significant  differences 
observed  in  this  study  between  controls  and  mild  forms, 
and  mild  and  severe  forms  of  a  thalassaemia  trait 
(p.( .001),  overlap  between  the  two  broad  groupings 
does  occur  (Figure  19).  Because  of  this  overlap 
between  the  groups,  it is  very  difficult  to  deal 
with  individual  cases  solely  on  the  basis  of  globin 
chain  synthesis  studies  (Weatherall  and  Clegg,  1981). 
For  example,  the  mild  form  patients  with  ratios  of 
0.99  and  1.0  are  very  comparable  with  several  in  the 
control  group  (Figure  19).  These  patients  are, 
however,  categorised  as  a  thalassaemia  trait  because 
of  a  significant  reduction  in  MCV  and  MCH  and  the 
presence  of  normal  ferritin  levels.  Globin  chain 
synthesis  studies,  therefore,  can  be  used  to 
separate  the  severe  form  of  the  trait  from  normals, 
but  is  unsuitable  for  use  as  a  diagnostic  test  for 
all  mild  forms,  since  minor  reduction  In  a  globin 
chain  synthesis  is  not  always detected  by  this  technique 
(Higgs  et  aI,  1980b;  Clegg  and  Weatherall,  1981; 
Higgs  and  Weatherall,  1983;  Weatherall  and  Wainscoat~ 
1985).  If  real  doubt  exists  regarding  diagnosis  of 
a  thalassaemia  trait,  gene  mapping  techniques  must  be 
undertaken. 
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MCV  and  MCH  ranges  were  used  to  separate  mild 
and  severe  forms  of  a  thalassaemia  trait  in  this 
study  (Figures  17  and  18).  These  results  are 
consistent  with  those  reported  by  Chanarin  et  al 
(1980)  indicating  their  values  as  discriminators 
for  the  mild  and  the  severe  forms  of  this  disorder. 
7.  HbH  INCLUSIONS  IN  a  THALASSAEMIA  TRAIT  PATIENTS 
All  patients  in  the  present  study  with  the  mild 
form  of  a  thalassaemia  trait  showed  negative  results 
on  HbH  inclusion  testing,  consistent  with  that 
reported  in  obligatory  carriers  of  a  thalassaemia  2 
(Pornpatkul  et  aI,  1976).  The  present  study  showed 
that  the  HbH  inclusion  test,  even  with  centrifugation 
could  not  detect  red  cell  inclusions  in  the  mild 
form  of  the  disorder,  supporting  the  suggestion  that 
HbH  production  is  too  low  in  those  patients  to  be 
detected  by  this  test  (Pornpatkul  et  aI,  1976). 
Therefore,  the  HbH  inclusion  test  has  no'  value  In 
the  diagnosis  of  the  mild  form  of  a  thalassaemia 
trait.  However,  in  the  severe  form  most  of  the 
patients  showed  positive  results  by  the  routine  and 
experimental  whole  blood  methods  (Pornpatkul  et  aI, 
1976;  Chanarin  et  aI,  1980).  However  by  the 
104 centrifugation  method,  all  patients  with  severe 
forms  give  a  positive  result.  This  indicates  that 
the  demonstration  of  HbH  inclusions  by  the  centrifugation 
method  can  be  used  as  a  reliable  test  to  detect  the 
severe  form  of  the  disease. 
According  to  McNeil  (1971),  the  co-existence 
of  iron  deficiency  and  a  thalassaemia  trait  may  lead 
to  "false  negative"  results  in  HbH  testing.  This 
report  is  inconsistent  with  the  results  obtained  in 
the  present  study,  where  two  patients  with  combined 
severe  a  thalassaemia  trait/iron  deficiency,  demonstrated 
a  positive  HbH  inclusion  test. 
8.  HETEROGENEITY  OF  a  THALASSAEMIA  TRAIT  IN  DIFFERENT 
ETHNIC  GROUPS 
8.1  Comparison  of  a  Thalassaemia  Trait  In  Indians  and 
Chinese 
8.1.1.  Indian  patients 
As  suggested  in  the  literature,  the  severe 
form  of  a  thalasssaemia  trait  does  not  exist  In  the 
Indian  community  (Walford  and  Deacon,  1976).  In  this 
study  both  forms  of  the  disorder  have  been  identifled. 
the  severe  form  being  demonstrated  in  six  Indian 
patients.  The  two  forms  can  be  clearly  separated  by 
measurement  of  MCV,  MCH  values,  HbH  inclusions  and 
a/B  chain  synthesis  ratios  [Table  XXI].  Because  of 
the  small  number  of  patients  examined  in  this  work. 
it  was  not  easy  to  reach  a  definite  conclusion  about 
105 the  major  form  in  the  Indian  community,  but  the  ratio 
of  mild  to  severe  forms  of  4:3  observed  in  this  group 
may  indicate  the  co-existence  of  the  two  forms  with  the 
same  frequency. 
8.1.2  Chinese 
In  the  Chinese  grouh  a  ratio  of  mild  to  severe  of 
1 :11  may  indicate  that  the  severe  form  is  the  most 
common  form  In  Chinese. 
8.1 .3  Red  cell  measurement 
A  comparison  of  the  severe  form  observed  in  the 
Indian  and  Chinese  populations  fails  to  show  any 
significant  difference  in  red  cell  indices  [Table  XIVJ. 
8.1 .4  Serum  ferritin  level 
8.1.4.1  Controls 
Although  regardless  of  sex  all  serum  ferritin 
levels  fell  within  the  normal  range,  values  in  males 
were  significantly  higher  than  in  females. 
8.1.4.2  Patients 
Although  there  is  no  significant  difference  ~n 
serum  ferritin  levels  between  all  male  patients  and 
male  contro~, comparison  of  Chinese  male  patients 
differs  significantly  from  male  controls  (p~ .01) 
and  male  Indians  (p", .001 )[Figure  24J.  This  may  be 
due  to  the  fact  that  all  Chinese  males  have  serum 
ferritin  levels  in  the  upper  normal  range,  as  an  ethnic 
characteristic,  while  Indians  have  ferritin  levels  in 
the  lower  range.  These  differences  do  not  exist  in 
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MEAN females  of  the  different  groups.  It  should  be  noted 
that  the  sex  difference  in  serum  ferritin  levels 
found  in  most  ethnic  groups  did  not  occur  in  Indians. 
8.1.5  HbH  Inclusions 
Although  there  IS  no  significant  difference  in  red 
cell  measurements  between  Indian  and  Chinese  with  the 
severe  form  of  the  disorder,  the  numbers  of  inclusion 
bodies  differ  greatly  between  the  two  races  regardless 
of  method  of  HbH  inclusion  testing  (Figure  20).  When 
ranked  In  order  of  severity,  HbH  inclusions  are  more 
easily  seen  and  more  numerous  in  the  Chinese  group 
(mean  29/30,000  RBC)  than  in  the  Indian  group  (mean 
2/30,000  RBC)  using  the  centrifugation  method.  With 
centrifugation  the  Chinese  group  showed  an  increase 
of  inclusion  numbers  about  five  times  that  obtained 
with  whole  blood,  while  the  Indians  showed  only  an 
increase  of  a  factor  of  three.  This  indicates  that 
with  any  improvement  in  the  HbH  inclusion  test  the 
ethnic  origin  of  the  patients  examined  should  be  taken 
into  consideration. 
8.1.6  Globin  Chain  Synthesis  Studies 
Despite  the  fact  that  the  number  of  HbH  inclusions 
In  Indians  is  about  1/5th  that  observed  In  Chinese 
using  the  whole  blood  method  and  1/15th  using  the 
centrifugation  method,  a/S  ratios  in  the  Indian  severe 
form  were  more  significantly  reduced  than  that  in  the 
Chinese  severe  form.  These  differences  in  a/S  ratios 
between  the  two  racial  groups  are  not  consistent  with 
107 the  observations  of  Walford  and  Deacon  (1976). 
The  above  comparisons  between  the  severe  forms 
of  a  thalassaemia  trait  in  Indians  and  Chinese  showed 
that  there  is  no  correlation  between  the  number  of 
HbH  inclusions  and  the  degree  of  reduction  in  alB 
ratio.  This  might  indicate  that  the  precipitation 
of  HbH(B 4 )  could  be  affected  by  other  factors,  related 
to  a  genetic  variation  between  different  populations, 
rather  than  the  amount  of  HbH  alone. 
In  this  study  the  Chinese  severe  form  showed  a 
h i g her  a I S  rat  i 0  (0.87  ill.  06 )  t han  t hat  rep  0 r ted 
previously  by  Kan  et  al  (1968),  Schwartz  et  al  (1969) 
for  mixed  Chinese  and  Italian  populations with  a 
thalassaemia  1  (0.77±.05). 
8.2  COMPARISON  OF  a"  THALASSAEMIA  TRAIT  IN  INDIANS  AND 
NEGROES 
The  only  Negro  patient  studied  had  the  severe  form 
of  a  thalassaemia  trait  with  red  cell  parameters,  HbH 
inclusion  bodies  and  globin  chain  synthesis  ratio 
exactly  as  those  of  Indian  origin.  However,  both  Negro 
and  Indians  with  the  severe  form  sf  a  thalassaemia  trait 
showed  red  cell  indices  and  alB  ratios  comparable  with 
those  observed  previously  for  obligatory  carriers  of 
a  thalassaemia  1  trait  in  Oriental  and  Mediterranean  races 
(Kan  et  aI,  1968;  Schwartz  et  aI,  1969).  However,  the 
number  of  inclusion  bodies  was  very  low  or  negative, 
unlike  those  of  Oriental  races  (Walford  and  Deacon.  1976). 
This  observation  has  been  demonstrated  previously  in 
108 Negroes  with  the  severe  form  of  the  disorder  (Higgs  et  aI, 
1979). 
The  absence  of  Hb  Barts  hydrops  foetalis  syndrome 
and  the  rare  occurrence  of  ~bH  disease  in  both  Indian 
(Weatherall  and  Clegg,  1981)  and  Negro  populations 
(Higgs  et  aI,  1979;  Dozy  et  aI,  1979)  together  with  the 
similarities  noted  in  the  trait  form  suggests  that  the 
genetic  disturbance  in  a  thalassaemia  in  Indians  is 
similar  to  that  of  Negroes.  Based  on  these  similarities 
the  genetic  studies  on  a  thalassaemia  trait  in  Negroes 
(Higgs  et  aI,  1979;  Dozy  et  aI,  1979)  can  be  used  to 
propose  the  inheritance  of  a  thalassaemia  trait  in  Indians. 
Accordingly,  the  mild  form  "a  thalassaemia  2"  in  Indians 
could  be  due  to  a  deleted  "or  inactivated"  a  chain  gene 
(-a/aa)  as  in  Oriental  a  thalassaemia  2  (Walford  and 
Deacon,  1976).  While  the  severe  form  may  be  due  to 
homozygous  a  thalassaemia  2  trait,  characterised  by  a 
deletion  of  2  a  chain  genes  in  trans  (-a/-a),  unlike  that 
of  Oriental  (Chinese)  heterozygous  a  thalassaemia  1, 
which  is  caused  by  a  deletion  of  2  a  chaio  genes  in  Cis 
(--/aa)  i.e.  from  the  same  chromosome.  Therefore,  the 
genotype  --/aa  1S  most  likely  to  be  rare  or  absent  in 
Indians  due  to  the  complete  absence  of HbBart's  hydrops 
foetalis  syndrome  (homozygous  a  thalassaemia  1)  in  this 
community. 
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Appendice  I 
20  successive  patients  will  a"  low  ferritin  (  13  ng/[7'.l., t~CV ~ 79 
and  Hb  between  10  and  15  g/dl  constitute  the  Iron 
deficiency  group  in  Figure  25.  These  are  compared  with 
the  25  uncomplicated  a  thalassaemia  trait  patients 
examined  in  this  study. 
The  iron  deficiency  patients  have  a  higher  ROW 
(17.6  ±  2.1)  compared  wit~  13.9  ±  0.7  for  those  with 
ex  thalassaemia  trait  (p~.001). 
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